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 The national prevalence of limb loss is approximately 1.7 million people.  Leading causes 
of this type of loss are diabetes and peripheral vascular disease.  Diabetics are more likely than 
non-diabetics to have an amputation.  Sixty percent of non-traumatic amputations occur in 
diabetics.  Although preventive care measures are improving for diabetics, the epidemiological 
rate of increase in diabetes will continue over the next thirty years.  The rate increase is projected 
to have an equal increase in the amputation rate.  Along with amputation, comes a pain sequela 
that becomes chronic in nature.  Pain management after amputation requires a specific regimen 
of pain control for the amputee.  Primary pain management in the acute hospitalization phase 
focuses on pharmacologic management. To date, no studies have examined a complementary 
intervention along with pharmacologic measures immediately after surgery.  
 The purpose of this study was to investigate the feasibility and efficacy of a 
desensitization protocol in the immediate postoperative period for patients who had a major 
lower limb amputation, along with the impact of demographic factors, clinical factors and 
treatment fidelity on pain level, use of pain medication, anxiety and depression.  Roy’s 
Adaptation Theory and Melzack’s Neuromatrix Theory of Pain provide the framework for this 
study. 
 Using a prospective repeated measure design with convenience sampling, data was 
collected from twelve patients after lower limb amputation surgery in a large medical facility in 
the southeastern United States. 
	  	  
 This study found that in the acute hospital setting after amputation surgery continuous, 
intermittent and neuropathic pain is present. Total pain intensity mean scores decreased during 
repeated measurement periods for each pain type.  Several correlations were noted in this study.   
Continuous pain and intermittent pain showed a significant correlation during all time periods of 
the study. By the last day of the study, present pain, SF-MPQ-2 total score, continuous pain, 
intermittent pain and neuropathic pain showed a strong correlation with medication dosing.  A 
number of other strong correlations were noted among the measures.  Feasibility of the 
desensitization protocol showed that all participants felt the protocol was easy to use.  The 
majority felt it helped their pain.  During self-administration of desensitization the participants 
recorded each intervention with a numerical pain score before and after intervention.  During 
postoperative days two through five, a large effect size was noted in paired comparisons of pain 
for each day that reached statistical significance. 
 This study supports previous studies that multiple types of pain are present after 
amputation surgery.  Overall, pain intensity scores decreased during the study.  Desensitization 
was supported as being feasible and efficacious as a complementary therapy for this sample. 
Nurses provide pain control measures to patients daily.  Finding ways to modulate the pain using 
self-administer techniques such as used in this study provides improved patient outcomes.  
Further studies need to be conducted in a larger sample on complementary pain measures.   
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CHAPTER 1:  INTRODUCTION	  
 
 Prevalence of limb loss in the United States is approximately 1.7 million people. 
(Ziegler-Graham, MacKenzie, Ephraim, Travison & Brookmeyer, 2008).  Limb loss occurs as a 
result of dysvascular disease, trauma, cancer and congenital anomalies.  Diabetes and peripheral 
arterial disease are the two prominent conditions causing the majority of limb loss.  Diabetic 
limb loss usually results from one of the following causes:  foot infection, foot trauma or 
peripheral arterial disease. Despite the cause, amputation surgery causes multidimensional pain 
for the individual that may end up in a chronic state.  A majority of amputees live with pain for 
their entire lives.  
Background and Significance 
 Pain associated with amputation surgery is complex.  In addition to postoperative pain, 
patients experience residual limb pain (RLP) and phantom limb pain (PLP).  Pain experienced 
after amputation can continue years beyond the surgery, resulting in a chronic pain state (Ehde & 
Smith, 2004; Fritz, Chaitow, Hymel, 2007; Galloway, Buckenmaier & Polomano, 2011).  The 
Institute of Medicine’s (IOM) recent report on Relieving Pain In America (2011) reports 116 
million adult Americans living with chronic pain. Chronic pain in the United States costs $635 
billion per year (IOM, 2011).  Pain is a public health problem recognized by the IOM with a call 
to adopt population-level strategies in treating this health problem.  Amputees are one of the 
populations represented in the IOM Report.  
Diabetes accounts for 60% of the non-traumatic amputations done yearly (CDC, 2011). 
The primary amputation site for diabetics is the lower extremity (CDC, 2011).  Age adjusted 
rates for people with diabetes that have a major lower extremity amputation is 5.5 per 1,000 
diabetics, which is 28 times higher than those without diabetes (NLLIC, 2008).  Prevalence of 
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diabetes is rising in the United States.  The CDC (2011) reported that the disease affected 25.8 
million people in 2010 with 18.8 million diagnosed cases and another 7 million undiagnosed.  
Epidemiological projection is that the rate of amputations will double by 2050 due to diabetic 
causes (Ziegler-Graham et al., 2008).   
In a recent study, Li, Burrows, Gregg, Albright and Geiss (2012) found that the rate of 
amputation was decreasing in the diabetic population.  The reason behind this decrease was not 
due to a decrease in the rate of diabetes but improved preventive care.  The authors found that 
amputation rates among diabetics who were forty years or older decreased from 11.2/1000 to 
3.9/1000.  Although this is a significant change, the authors noted that lower extremity 
amputations are much higher in the diabetic population when compared to people without 
diabetes.  Rates are particularly high for those greater than or equal to 75 years old, African 
Americans and men.  Even though the study reported improvement in rates of lower extremity 
amputation, it did not take into account the projection of the epidemiological rate of diabetes or 
those who are undiagnosed.   Ziegler-Graham et al. (2008) anticipate that the rate of amputation 
will increase due to improved measures to detect diabetes at an earlier stage over the next thirty 
years.  Diabetic lower extremity amputation will not be solved by preventive care.  The 
association of the disease and outcome may be slowed, but amputations will continue to be a 
concern for the future. 
   Another major dysvascular condition that ends in primary amputation is peripheral 
arterial disease (PAD).  Peripheral arterial disease affects 3-6% of the population over age 55 
(Gregg et al., 2004; McCollum & Raza, 2004).  Prevalence of PAD increases with age with an 
escalation of up to 20% at 70 years of age (Hirsch et al., 2006).  Severe PAD leads to lower 
extremity limb amputation due to infection and tissue loss from lack of adequate blood flow.  
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Diabetes can be the cause of PAD, but not in all cases.  Those that have diabetes and PAD are at 
greatest risk for limb loss (McCollum & Raza, 2004).  PAD is increasing in our nation due to an 
increase in the elderly population (McCollum & Raza, 2004). The symptoms of PAD sometimes 
go unrecognized and undiagnosed until it is too late to salvage the limb.  Only 10% of people 
with PAD have intermittent claudication, which is the classic symptom for the disease (Hirsch et 
al., 2001).  One study found up to 63% of the participants that tested positive for PAD by ankle 
brachial indices had no claudication symptoms (McDermott, Fried, Simonsick, Ling & Guralnik, 
2000).   
 People with diabetes and/or peripheral arterial disease that have an amputation deal with 
acute and chronic pain. Chronic pain occurs in 72% to 80% of amputees (Ehde et al., 2000; 
Hanley et al., 2007; Richardson, Glenn, Horgan & Nurmikko, 2007).  There is some evidence 
that severe acute pain in the postoperative period is related to increased chronic pain 
(Dunworthy, Krenzischek, Pasero, Rathmell & Polomano, 2008). Chronic pain causes suffering, 
inability to perform activities of daily living, inability to participate in rehabilitation, 
psychological strain and sometimes a dysfunctional home environment due to the role strain 
from the constant presence of pain (Bosmans, et al., 2007; Dudgeon, Gerrard, Jensen, Rhodes & 
Tyler, 2002; Ehde et al., 2000; Ellis, 2002).  Therefore, minimizing acute pain in the post-
operative period may have long-term positive benefits. Although there is some evidence to 
support this, few non-pharmacological interventions have been tested in the post-operative 
period. In particular, there is a dearth of literature on interventions targeting phantom pain and 
residual limb pain in the acute setting. 
In a recent analysis of pain management options for neuropathic pain, Knotkova, 
Cruciani, Tronnier and Rasche (2012) found that a limited number of control studies have been 
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done to assess drug efficacy in this type of pain.  They also found that of the limited studies 
available, inadequate methodology was used.  After review of the literature, the authors 
concluded that since neuropathic pain is chronic in a majority of amputees that pharmacologic 
treatment does not provide adequate relief and supportive treatments must be used to enhance the 
treatment regimen.  
 The pain experience encompasses both physiological responses and psychological 
processes.  Craig (2006) described pain and emotion as reciprocal influences.  Although pain 
management is focused primarily on the sensory aspect of the physiological responses and is 
reported via pain scales, there is little to no attention placed on the affective component of pain.  
Craig (2006) noted that pain management is largely one-dimensional due to the lack of treating 
both the sensory and affective component of pain.   Two of the basic emotions experienced in 
pain processes are anxiety and depression.  
 Anxiety is a psychological response to pain often experienced in the new amputee.  
Studies have reported rates of anxiety after amputation to be from 17.6% to 37% (Atherton & 
Robertson, 2006; Desmond & MacLachlan, 2006; Coffey, Gallagher, Horgan, Desmond, 
MacLachlan, 2009; Hawamdeh, Othman & Ibrahim, 2008; Singh et al., 2009).   A correlation 
exists between pain and anxiety.  The greater the amount of anxiety then the worse the 
postoperative pain experienced (Craig, 2006).  Acute pain, such as that found in the immediate 
postoperative period, generates anxiety, as well as, when there is a change in the pain level 
(Craig, 2006).  Not only can anxiety change the level of pain, but it can also cause physical 
decompensation (Craig, 2006).   The pain-anxiety-tension cycle can lead to physical decline 
from the pain by causing muscle tension at the site of injury which results in vasoconstriction, 
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ischemia and release of enzymes stimulating the pain pathway (Keefe & Gil, 1986).  The anxiety 
heightens the pain leading to a prolonged cycle of pain.    
 Anxiety does not occur as the only affective disorder in the amputee.   Depression is 
often present.  Depression related to amputation has been reported in a number of studies, with 
rates reported from 13.4%, to as high as 41.7%  (Atherton & Robertson, 2006; Cansever, Uzun, 
Yildiz, Ates & Atesalp, 2003; Darnell et al., 2005; Desmond & MacLachlan, 2006; Coffey et al., 
2009; Hawamdeh et al., 2008; Singh, Hunter & Philip, 2007).  Craig (2006) discussed that both 
positive and negative moods are capable of altering pain.  Depression, a common negative 
reaction to the process of amputation, can alter pain tolerance.  Most studies linking depression 
and amputation pain have been conducted after the patient is in a chronic phase of pain  (Castillo, 
Mackenzie, Wegener & Bosse, 2006; Desmond & MacLachlan, 2006; Whyte & Niven, 2001).   
In studies done on chronic amputation pain there are mixed reports as to whether pain and 
depression have a synergistic effect.  Desmond and MacLachlan (2006) found significant 
differences between types of amputation pain and depression.  Castillo et al. (2006) found that 
high levels of depression post discharge were related to chronic pain in the lower extremity 
amputee.  Whyte and Niven (2001) found that the depression might be related to the disability 
and not necessarily the pain.  No studies were found studying depression in the acute 
postoperative setting relating to the pain experience.  
Statement of the Problem 
 Pain management in the amputee is a difficult task due to the multidimensional aspects of 
pain and affective disorders that contribute to the total pain experience.  Craig (2006) noted the 
inability of the health care practitioner to adequately assess for both the sensory and affective 
processes of pain due to limited tools for assessment.  Treating the complexity of amputation 
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pain with interventions for both sensory and affective qualities is imperative to help prevent a 
chronic, debilitating pain in the future. At present, pain management in the acute phase after 
amputation is normally treated by opioids. Additional pain management in the form of 
complementary therapies need to be incorporated into pain control measures for the amputee.  
 Desensitization, a non-invasive, complementary therapy is a technique, similar to 
massage, that is found in instructional texts for interdisciplinary health care students.  It is 
purported to decrease pain and help with adjustment to body image (Huang & Kuiken, 2004).  
However, no studies have been conducted to verify this information.  Studies using the 
complementary therapy of desensitization are needed in order to substantiate practice.  Since no 
established protocol was found in textbooks or practice settings, this pilot study will test a 
protocol developed by the author and evaluate its feasibility, efficacy and effect on pain after 
amputation surgery.    
Physiological Mechanisms of Pain after Amputation 
In order to understand the theory related to this study, knowing the physiologic 
mechanisms causing amputation pain is necessary. 
Pain after amputation surgery is not only caused by the stress of surgery but is related to 
the induced injury of the tissues from the actual procedure.  Pain after surgery is acute and 
should not be long lasting.  Damage to the peripheral nervous system caused by the amputation 
procedure may lead to a chronic pain syndrome (Fritz et al., 2007).  If pain in the acute phase is 
not optimally managed, the patient’s outcome may be a chronic pain syndrome.  Galloway, 
Buckenmaier & Polomano (2011) reported that unresolved acute pain leads to chronic pain in the 
amputee.  Ehde and Smith (2004) also discussed how pain after amputation can transition to a 
	  	   7	  
chronic state and limit quality of life and functional ability.  Daniel (2008) stated that inadequate 
postoperative management of pain increases the risk of chronic pain.  
Pain Pathway after Amputation 
 Firing of the nociceptors causes pain after amputation surgery.  The skin possesses more 
nociceptors than muscle, bone or visceral tissue (Fritz et al., 2007) Chemicals are released at the 
site as a response to the injury of surgery. In the case of	  amputation it is tissue and nerve injury 
due to the severing of the limb that causes firing of millions of these nociceptors.  The action 
potential of the nerve sends signals to the dorsal root ganglion of the spinal column where the 
pain gate is opened and transmission occurs through the ascending tract to the medulla and 
thalamus (Meyer, Ringkamp, Campbell & Raja, 2006; Nikolajsen & Jensen, 2006). Two types of 
fibers exist in the spinothalmic tract that transmits the signals from nociceptors.  The pain sent 
from the nociceptors is transmitted along small or A-delta fibers, which are rapid transmitting 
fibers.  The A-delta fibers respond to signals of weaker intensity.  The C-fibers are large 
diameter, slow transmitting pathways that respond to signals of greater intensity or magnitude.    
The C-fibers synapse at the dorsal horn sending the signal through an ascending pathway 
(Galloway et al., 2011).  If pain is not managed properly in the acute care setting then the C-
fibers cause a constant firing and dorsal horn excitability.  The stimulation of C-fibers is 
accomplished through rubbing which results in decreased sharp pain sensation (Fritz et al., 
2007).    
  Transmission through the ascending path travels to the medulla and thalamus and then to 
the somatosensory parts of the brain.  Simultaneously a descending pathway is activated during 
initial pain sensation.  The descending pathway is an inhibitory pathway that should prevent 
some of the pain signals from being sent to the brain (Galloway et al., 2011).  It is through the 
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ascending and descending pathways that the individual perceives pain. Treatment is aimed at 
reducing the excitation of the ascending pathway and increasing the inhibitory system of the 
descending pathway  (Galloway et al., 2011).   
Acute to Chronic Pain Transition 
 The transition point from acute to chronic pain is critical.  Sensitization with changes in 
the peripheral or central nervous system causes this transition (Galloway et al., 2011).  The 
inflammatory process that occurs with the healing of the tissues causes a reduced threshold at the 
periphery for nociceptors.  The results are a prolonged and heightened response to pain 
manifesting as hyperalgesia or an extreme sensitivity to pain caused by neuronal hyper-
reactivity.  It can also cause allodynia or pain from stimuli that are not typically painful, such as 
light touch.  (Galloway et al., 2011; Meyer et al., 2006; Nikolajsen & Jensen, 2006).   
 Neurons in the dorsal horn of the central nervous system become sensitized with the 
constant transmission of painful stimuli occurring from C-fiber stimulation.  This process is 
called central sensitization. (Meyer et al., 2006; Nikolajsen & Jensen, 2006)  During this process 
changes occur in receptors and neuron structures leading to an overactive pathway transmission 
to pain and sensation.  The threshold to block painful stimuli from transmission to the brain 
lowers.  The outcome is pain that transitions from an acute state to a chronic state (Daniel, 2008; 
Galloway et al., 2011).   
 A second change that occurs during central sensitization is independent firing of neurons 
from the periphery without a stimulus.   Firing without a stimulus is called wind-up.  Firing of 
the peripheral neurons sends a continuous signal through the pathway thus lowering pain 
inhibition even further.  The central nervous system forms a maladaptive pattern of processing 
pain at this point.  The neuron structure and pain processing mechanism are redefined in this 
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maladaptive firing and are unable to inhibit the pain.  The restructuring is called neuroplasticity.  
Results are a chronic pain state including phantom limb pain (Galloway et al., 2011).   
 During this transition the pain has been largely uncontrolled.  The dorsal horn has to be 
desensitized to increase the pain threshold and inhibit transmission.  Pain caused by 
neuroplasticity and wind-up are resistant to analgesics (Galloway et al., 2011).  The need for pain 
management in this type of pain is through alternative management strategies (Galloway et al., 
2011).  
Theoretical Frameworks 
  The nursing theory used in this study is Roy’s Adaptation Model, which will help 
structure the variables surrounding amputation pain, treatment and the neuromatrix theory of 
pain.  The neuromatrix theory also will provide a framework for understanding how the 
intervention works with the amputation pain pathway. 
Roy’s Adaptation Model 
 Roy’s Adaptation Model is the guiding nursing framework for this study.  An assumption 
of this theory is that individuals have the ability to accept input, control the input and form a 
responsive output (Roy, 2009). In new amputees a positive response would be adaptation to a life 
without a limb and without pain.  Unfortunately, amputees struggle with pain and pain interferes 
with daily life.  Pain is the primary input in the immediate postoperative period eliciting the need 
for an adaptive response.  If pain is uncontrolled, it may become chronic and negative adaptation 
will be the outcome (Hanley et al., 2007).  Macrae, Powell & Bruce (2008) report that the 
incidence of chronic pain after lower limb amputation surgery occurs in 50 – 85% of patients 
which shows that at present inadequate pain control of the amputation patient is an on-going 
problem.  
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 Input (Stimulus).  Roy (2009) describes a focal stimulus as the immediate input that the 
system experiences.  In an amputee, the focal stimulus is pain within an acute setting.  The 
experienced pain may be heightened by other stimuli.  Roy (2009) refers to contextual stimuli as 
all other stimuli that enhance the focal stimulus.  Contextual stimuli influence how the individual 
deals with the focal stimulus (Roy, 2009).  Contextual stimuli aggravating the pain experience 
for the amputee can include patient characteristics, clinical characteristics, prior pain experience, 
anxiety and depression.   Patient characteristics that may contribute to the pain experience are 
age, gender, race and educational level.   Clinical characteristics may also affect pain and include 
surgical procedure, underlying disease cause, comorbid conditions and anesthesia used during 
the procedure.  Pain experienced prior to the surgery can also contribute to the amount of pain 
experienced after the amputation.  Anxiety and depression are common experiences related to 
surgery.  The amount of anxiety and depression of an amputee may lead to heightened states of 
pain in the postoperative period resulting in a chronic pain state (Castillo, et al., 2006). 
 Coping Strategies (Adaptation).  Coping or controlling of the pain is important after 
amputation.  Roy (2009) divides coping processes into subsystems of cognator and regulator for 
the individual.  Coping processes for the amputee in the acute setting primarily relate to effective 
pain control following surgery.  The cognator and regulator system of the human body carry out 
life processes.  The result of the system can be integrated, compensatory or compromised.  The 
amputee’s ability to deal with the stimulus of pain in an integrated and compensatory manner 
will lead to a positive response.  Constructive changes show when adaptation has occurred.  If 
the system fails to effectively deal with the changes then a compromised state will occur. The 
response will act as a feedback to the system seeking a homeostatic level (Roy, 2009). The two 
systems make up the total experience of pain sensation by the individual.  
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The regulator system as described by Roy (2009) follows the physiological responses of 
the pain pathway noted earlier. The regulator system is the neural, chemical and endocrine 
responses the pain elicits internally.  Roy describes the regulatory actions as primarily autonomic 
in nature, although some can be imposed externally. After amputation, the effect of surgical 
separation of the tissue, bone and nerves starts the process of the regulator system causing pain. 
The cognator subsystem uses four channels which are; emotion, perceptual and 
information processing, learning and judgment (Roy, 2009).  It is through the perceptual and 
information processing channel that Roy says attention, coding and memory are linked to the 
stimulus.  The channel of learning deals with imitation, reinforcement and insight. Judgment is 
comprised of problem solving and decision-making.  Roy explains emotions as the person’s 
relief from anxiety or affective circumstances.  In the amputation patient in the acute setting, the 
pain after arousal from surgery enacts the processes of attention, coding and memory linking it to 
past pain experiences.  In essence, this is why someone can rate his or her pain scale 
comparatively. The person has had prior experience with pain and possibly surgery and has 
learned about pain after this experience.  Judgment of the pain experience is seen when the 
individual decides on the course of action to take.  Often this results in needing some form of 
pain relief, i.e. asking for pain medication.  Emotion, as Roy describes in her model, centers on 
affective feelings, one being anxiety.  Emotions for some one sustaining limb loss heightens the 
pain experience.  The four channels of the cognator system are used during pain processing in 
the amputation patient.  Roy (2009) sees the pain experience as part of the sensory adaptation of 
the individual.  Therefore, a stimulus causes the sensation of pain.  This is easily related to the 
amputation of surgery. But, what is not understood is pain caused when there is no sensory input, 
as that caused from a phantom limb.    
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Behaviors (Outcome).  Processing of the input or stimuli through coping processes 
results in a behavioral response.  Behaviors can be internal or external (Roy, 2009).   External 
pain behaviors may be observed, such as an elevated heart rate. Internal behaviors are more 
prevalent in amputation pain.  The internal regulator system is automatically trying to deal with 
the pain.  It is only when this system fails that behavior changes.  This occurs immediately after 
the amputation.  The physiological distress of neuropathic pain and residual limb pain are 
prominent sensations needing adaptive coping.  Nurses must assess internal and external 
behavior in order to help with adaptation.  
  The outcome of adaptation can be integrated, compensatory or compromised (Roy, 
2009).  Integrated adaptation occurs when the person meets basic human needs such as, 
oxygenation, food and water.  Compensatory adaptation occurs when coping is needed to 
establish holism again.  Compromised adaptation occurs when a failure of integration and/or 
compensation occurs (Roy, 2009).  In the acute postoperative period, the amputee is in a 
compensatory state trying to seek ways of controlling the pain. If the person is successful with 
pain control, then an integrated and compensatory state occurs and the person has adapted.  If 
this is not effective, then adaptation is compromised.  Prolongation of a compromised state 
during the pain experience will result in a poor patient outcome (Roy, 2009).  The result of 
compromised adaptation is chronic pain.  
Neuromatrix Theory 
As discussed in Roy’s theory, the subsystem of the regulator and cognator, explain the 
response to the sensation of pain caused by the amputation surgery.  What is not clear is what 
happens when there is no sensory input.  The lack of sensory input from a phantom limb is 
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difficult to explain due to there being no neural, hormonal or chemical inputs to evoke this type 
of pain.  
Explanation related to coding for phantom limb pain is addressed in the work of Dr. 
Melzack’s Neuromatrix Theory.  Melzack (1999) suggests that phantom limb pain does not 
follow the traditional physiological response.  A belief in this theory is that a neural process of 
the brain makes the phantom pain seem real to the individual in the absent of any type of input. 
Melzack also based this theory on the body having a genetically predisposed brain process that 
through the course of living has been modified.  
Melzack (1999) describes a matrix of neurons extending through the body that produces 
repeatable nerve impulse patterns. This matrix is formed genetically but through life the patterns 
may be transformed.  He describes this as the neuromatrix with patterning or loops in the 
thalamus, cortical and limbic regions of the brain that process the inputs cyclically. This process 
produces an output he terms the neurosignature.  Unlike Roy, Melzack believes that the pain is 
more than sensory.  He believes the pain experience upsets the brain’s homeostasis causing 
stress, which leads to activation of the hypothalmic-pituitary-adrenal pathway.  This results in 
release of adrenocorticotropic hormone (ACTH), which in turns acts on the adrenals to release 
cortisol.  If pain is not modulated then cortisol can be produced excessively, leading to a chronic 
pain state.  
According to Melzack (1999), the hyperactivity of constantly firing neurons from severed 
tissues produces a referred pain pattern that is distinct in areas without nerves. It is through the 
constant barrage of neuron firing and genetically predetermined neurosignature of pain that the 
brain reacts to the phantom pain experience.  Melzack (2001) states that in order for this internal 
coding to be reestablished, restructuring has to occur.	  	  The	  primary	  way	  to	  stop	  an	  established	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and	  innate	  pain	  pathway	  in	  the	  body	  is	  by	  establishing	  a	  new	  pathway	  through	  stimuli	  at	  the	  site	  (Melzack,	  2001). 
Research Questions 
 Specific questions that will be addressed in this study are: 
(1) What are the demographic (age, gender, ethnicity, education level)  and clinical 
characteristics (type of amputation, reason for amputation, pre-amputation pain 
management) of the lower limb amputee patients in the study? 
(2) a. What are the patterns of pain quality, total pain, type of pain, pain management 
(opioid use), anxiety and depression in the immediate post-operative period on 
postoperative day (POD) 2, 4 and 6? 
 b.  What are the relationships among pain quality, total pain, type of pain, pain 
management, anxiety, and depression in the immediate post-operative period  on 
POD 2, POD 4 and POD 6? 
(3) a. What is the acceptability and feasibility of a desensitization intervention 
(recruitment, retention, patient acceptance, ease of use) for lower limb amputees in 
the post-operative period? 
b. How does the desensitization intervention affect self-reported short-term pain in 
lower limb amputees during the immediate post-operative period?  
Definition of Terms 
 Conceptual Definitions. 
 For the purposes of this study the following terms are conceptually defined as: 
 Amputee includes any male or female that is 18 years of age or greater that has a lower 
extremity amputation at the transfemoral, transtibial or knee disarticulation level.   
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 Lower limb amputation is the process of removing a limb by division through the long 
bone of the leg or through the knee (Browker, 2004). 
 Pain is the sensory, affective, behavioral and cognitive personal experience resulting 
from induction of noxious stimuli (Roy, 2009). 
 Acute pain is pain that is short in duration and has an identifiable cause with an expected 
time course (Roy, 2009). 
 Chronic pain is pain that persists and does not have a predictable time limit that may or 
may not have an identifiable cause with an expected time course (Roy, 2009).  
 Neuropathic pain is the sensory experience in the missing area after removal of a body 
part.  It is also called phantom pain (Middleton, 2003). 
 Nonneuropathic pain or nociceptive pain is pain resulting from physiological activation 
of the peripheral and central nervous system that actual tissue injury (Haanpää & Treede, 2010). 
 Depression is	  a	  change	  in	  mental	  mood	  that	  is	  accompanied	  by	  feeling	  down	  with	  a	  loss	  of	  interest	  in	  normal	  activity,	  feelings	  of	  low	  self	  esteem,	  lack	  of	  sleep,	  poor	  appetite,	  diminished	  energy,	  and	  lack	  of	  concentration	  (World	  Health	  Organization,	  2014). 
 Anxiety is a transitory and unpleasant emotional response that is preceded by a perceived 
threat leading to tension and apprehension (Daniel, 2008) 
 Operational Definitions. 
 Anxiety and depression were operationalized in this study by completion of the Hospital 
Anxiety and Depression Scale (HADS), consisting of 14 questions measured on a four-point 
rating scale from 0 to 3 being answered.  The participants rated two subscales with 7 questions 
for anxiety and 7 questions for depression.   
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 Neuropathic pain and nonneuropathic pain were measured by the completion of the Short 
Form McGill Pain Questionnaire-2 (SF-MPQ-2) consisting of 22 items measured on an eleven-
point scale from 0 to 10.  The questionnaire is subdivided into four scales; continuous, 
intermittent, neuropathic and affective descriptors. Nonneuropathic pain consists of the two 
subscales of continuous and intermittent pain measured by this instrument.   
Conceptual Model 
 In the conceptual model for this study, Roy’s Adaptation Model is used as a basis for 
construction for the proposed research.  The input is made up of the focal stimulus of amputation 
pain with the contextual stimuli represented by patient characteristics, clinical characteristics, 
pre-intervention pain control, anxiety and depression.  Coping (adaptation) strategies for the 
amputee is done through the use of available pain management.  All patients receive a prescribed 
regime of medication for their pain after surgery, usually consisting of an opioid.  Roy (2009) 
discusses pain compensation as a complex biological and behavioral process that is difficult to 
manage within the context in which it occurs.  Because of this difficulty, Roy (2009) feels that a 
person experiencing pain often loses the ability to compensate and becomes compromised in 
trying to adapt.  Roy (2009) identifies nurses as the healthcare professional that can assist the 
person with pain adaptation.  Although, Roy does feel nursing often bypasses the need for more 
than one intervention to help with pain adaptation.  In assisting with this adaptation, a 
complementary therapy, desensitization, is proposed for pain relief.  Through the use of both 
pharmacologic therapy and desensitization, the outcome for the patient may be a decrease in the 
level of neuropathic and non-neuropathic pain, as well as, reduced anxiety and depression which 
will lead to a compensated state for the new amputee. See Figure 1. 
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  Model based on Roy’s Adaptation Model (2009). 
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Summary 
 Currently 1.7 million people live with limb loss.  The majority of these individuals have 
received an amputation due to a dysvascular cause with diabetes being the leader of lower limb 
amputation.  Individuals diagnosed with diabetes are escalating with 18 million currently 
diagnosed and another 5.9 million that are undiagnosed.  Of total amputations done, 60% occur 
in the diabetic population.  
 Pain is a major outcome of those having an amputation.  The pain is multidimensional 
and difficult to treat.  Pain not only has a physiological cause but also an affective component.  
The new amputee is typically treated with standard pharmacologic pain medication as a result of 
an assessment completed on a numerical pain scale. The affective components of pain are not 
assessed and therefore left untreated.  The lack of treatment of the holistic biobehavioral process 
of the pain experience in the amputee leads to a chronic state of pain that has long lasting effects 
on functionality, recovery and daily productivity (Huang & Kuiken, 2004).  
 In order to treat all aspects of amputation pain, effective treatment must be employed.  
Research on pain lacks the use of complementary therapies that can accompany the 
pharmacologic regime.  Desensitization is a complementary therapy that has been discussed as a 
possible treatment for this population but has gone unresearched as an adjunct in pain 
management despite it being taught in didactic classes for professional health care personnel.  
Furthermore, no research has used complementary therapies in the time period immediately 
following amputation surgery.    
 
 
 
	  	  
CHAPTER 2:  REVIEW OF THE LITERATURE 
 The purpose of this pilot study is to examine the efficacy and feasibility of a 
desensitization protocol on pain management of the postoperative amputation patient in the acute 
care setting.  This chapter is a review of the pertinent literature relevant to the variables in the 
conceptual model.   The chapter will include three main categories represented by pain as the 
focal input, contextual input, and coping strategies.  Contextual input variables include patient 
characteristics, clinical characteristics and pre-surgical control of pain, anxiety level and 
depression level.  Variables representative of coping strategies after surgery include pain 
medication regimen and the intervention of desensitization.  Finally the chapter will conclude 
with an explanation of Roy’s Adaptation Model and Melzack’s Neuromatrix theory as the 
theoretical basis of this study. 
Focal Stimulus:  Pain 
  Pain is the immediate response following amputation surgery.  It is this focal stimulus 
that elicits the individual to seek strategies to resolve the pain in order to reestablish a 
homeostatic state of being.  The pain experienced after amputation often prevents the patient 
from developing suitable strategies to cope with the pain.  Two types of pain are experienced by 
the amputee, residual limb pain and phantom limb pain or neuropathic pain. The amputee does 
not usually experience just one of these types of pain.  Both pain types are reported in the 
amputee beginning in the immediate postoperative period (Flor, 2002; Nikolajsen & Jensen, 
2001; Wiffen et al, 2006).  Bloomquist (2001) and Richardson (2008) describe amputation pain 
as complex and multidimensional, making it difficult to treat.  
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Phantom Limb or Neuropathic Pain   
Phantom limb pain (PLP) is the sensory experience of pain in the missing limb after 
removal (Middleton, 2003). Haanpää and Treede (2010) describe this neuropathic type of pain as 
a direct result of a lesion or a disease that has direct affect on the peripheral and central nervous 
systems.  Studies on phantom limb pain have mainly focused on prevalence and descriptors of 
the pain.  
 Prevalence.   Studies measuring the prevalence of phantom limb or neuropathic pain 
have reported ranges from 63% to 85.6% in the literature (Clark, Bowling, Jepson & 
Rajbhandari, 2013; Ehde et al., 2000; Ephraim, Wegener, MacKenzie, Dillingham & Pezzin, 
2005; Gallagher, Allen & MacLachlan, 2001; Hanley et al., 2006a; Jensen et al., 2002; Kern, 
Busch, Muller, Kohl & Birklein, 2012; Probstner, Thuler, Ishikawa & Alvarenga, 2010; 
Richardson et al., 2007: Smith et al., 1999).  The mean time since amputation ranged from 4 
years to 18 years (Ehde et al., 2000; Ephraim et al., 2005; Hanley et al., 2006a; Smith et al., 
1999).  Studies on prevalence of PLP have taken place after respondents have reached a chronic 
pain state. 
 Two studies were longitudinal (Bosmans, Geertzen, Post, van der Schans & Dijkstra, 
2010; Castillo et al., 2006).  Bosmans et al. looked at PLP over a three and a half year period of 
time.  The study used a repeated measures design with surveys given at five days postoperative, 
1 ½ years, 2 ½ years and 3 ½ years.  Included in the sample (n = 85) were both upper and lower 
limb amputees. The authors found that PLP in lower extremity amputees decreased over the first 
2 ½ years, but then started increasing again at the 3 ½ year mark.  Limitations of the study 
included attrition rate of the sample and lack of instrument reliability and validity.  The initial 
sample started out with an n = 225 and due to attrition over half of the sample was lost to follow-
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up.  The instruments used were the only ones available in the Dutch language and had not been 
tested for reliability and validity.   
 Castillo et al. (2006) used secondary data from a national study to look at prevalence of 
chronic pain seven years after lower limb amputation due to trauma.  Several predictors of 
chronic pain were found to be statistically significant in the sample (n = 397).  These predictors 
were; less than a high school and college education, low self-efficacy and high alcohol use.  The 
study also showed high pain intensity starting at three months post discharge.  They found that 
only 22.9% of the sample was pain free after seven years.  The chronic pain was associated with 
the experience of PLP.  The study was limited by secondary data and confounding variables.  
 Ephraim et al. (2005) performed a cross sectional study of a national sample (n = 914) 
through the Amputee Coalition of America (ACA) over a two year period using a telephone 
survey.  The authors measured prevalence, intensity and bothersomeness of pain with a 
convenience sample.  Ninety-five percent of the sample reported pain in the previous month.  
Mean time since amputation in the total sample was four years.  Phantom pain was more 
prevalent (79.9%) than residual pain (67.7%).  The phantom pain was usually severe (7-10 on a 
1-10 scale) and extremely bothersome. The authors concluded that chronic pain after amputation 
was a problem.   
 In a study by Smith et al. (1999) frequency, intensity, bothersomeness and treatment were 
measured in a sample of 92 amputees. They found 63.3% experienced PLP.  The majority of 
participants reported their phantom pain as severe in intensity but only mildly bothersome.  The 
majority of participants (63.3%) had not used any prescription medication for relief of this type 
of pain.  Of those participants that did take medication, 35.5% took medicine on a daily basis.  
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The study is limited by generalizability since the population was primarily white (84%), 
educated (51%) above high school level and male (84%).   
 Hanley, Ehde, Campbell, Osborn and Smith (2006b) looked at similar variables with 
PLP, as did Ephraim.  Pain prevalence, intensity and severity along with prevalence of 
treatments used by the participants. The study was conducted as a secondary analysis of a larger 
study.  In the lower extremity amputee sample (n = 255) the prevalence of pain was 72%. 
Phantom limb severity on the average was rated as a 5.1 on a 1-10 scale.  Pain intensity was 
moderate for 26% and severe for 31% of the sample.  In reporting treatment, it was found that 
53% of the sample had never used any treatment for their PLP.  At the time of the study, 43% 
were currently using treatment of medications and non-pharmacologic modalities.  Respondents 
that used treatment reported higher phantom pain levels in the previous three months and 
experienced higher levels of disability.  The main treatment used was pharmacologic therapy of 
opioids with acetaminophen (22%) being the most frequently used.  Physical therapy was the 
main non-pharmacologic therapy used (16%).  Massage had been used in the past by 48% of the 
respondents and was considered moderately to extremely helpful.  The authors concluded that 
more research is needed on effective treatments for phantom pain.  
 In a recent study by Kern et al. (2012), 537 participants in Germany were surveyed by 
questionnaire about PLP.  Of the 74% that suffered from PLP, a majority (42%) had never been 
informed about PLP.  Most patients went untreated when they experienced this type of pain.  
Those that were treated averaged seeing three health care professionals before intervention was 
done. Limitations of the study were convenience sampling using a mailed questionnaire and also 
support for the study by a prosthetic company.  
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 Descriptors.  Researchers have studied amputee’s description of phantom pain to 
become familiar with the characteristics of this type of pain (Clark et al., 2013; Bosmans et al., 
2007; Dudgeon et al., 2002; Dudgeon et al., 2005; Ehde et al., 2000; Jensen, Smith, Ehde & 
Robinson, 2001; Mortimer, Steedman, McMillan, Martin & Ravey, 2002; Richardson et al. 2007; 
Smith et al., 1999; Warms, Marshall, Hoffman & Tyler, 2005).  Several of the studies were 
qualitative (Bosmans et al., 2007; Mortimer et al., 2002; Warms et al., 2005), one study used a 
mixed method design (Dudgeon et al., 2005) and the rest of the studies were quantitative. 
 One qualitative study used a phenomenological approach to describe chronic pain 
experienced in disabled individuals (Dudgeon et al., 2002).  Three groups of disabled individuals 
were interviewed with one of these groups being amputees.  The sample consisted of nine 
participants with 3 participants in each group.  Themes arising from the study were that pain is a 
mystery, pain is plural and pain is personal. The entire sample said pain was a mystery and they 
had to be a self-advocate with medical personnel to get treatment for this pain by giving direction 
to the physician or nurse to help them.  Limitations of the study are sample size with only three 
participants for each disability and results were not specified per disability.   
 Dudgeon et al. (2005) several years later used a mixed method sample to describe pain 
among the disabled.   The qualitative sample used the same three disabled groups with a sample 
of 28 participants. Nine of the participants had lower limb amputations. The phenomenological 
approach of this study found that descriptors of pain from the amputation group included 
squeezing and pinching for musculoskeletal pain while zinging, buzzing and knotted were the 
descriptors for neurologic pain.  Dudgeon et al. used a modified McGill Pain questionnaire with 
24 descriptors to quantitatively measure frequency of descriptors used per group.  Each group 
was analyzed for frequency.  The authors suggested using a set of the top fifteen words.  The top 
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fifteen descriptors for the amputee group were:  sharp, tingling, shooting, stabbing, throbbing, 
aching, shocking, piercing, cramping, tiring-exhausting, stinging, nagging, tight, hot-burning and 
radiating. One strength of this study compared to Dudgeon’s previous study was that results were 
specific per disability.   
 Mortimer, Steedman, McMillan, Martin and Ravey (2002) found similar findings in 
regards to descriptive words used by patient’s experiencing phantom limb pain.  In this focus 
group designed study, pain was described as shooting, shocking, sticking, stabbing, burning, 
cramping and crushing.  The authors found that people living with this type of pain were not 
educated nor were they able to articulate information about the treatment.  In Warms et al. (2005) 
a secondary analysis of comments written in the margins of a pain survey were explored.  
Amputees were a subset of the sample. The overarching theme was the need to speak with others 
about the experience of pain.  The respondents lived with pain daily without adequate 
information from health care professionals on how to treat this pain.  Warms et al. study lends 
support to the findings of the Mortimer et al. study in the lack of information the person receives 
regarding phantom pain and its treatment.  
 In a quantitative analysis of phantom pain, Ehde et al. (2000) looked at a large sample (n 
= 255) of community dwelling lower limb amputees for frequency, duration, intensity, disability 
and descriptors.  The sample was predominantly male (81%), well educated (87%) and white 
(86%).  The mean time since amputation was 14.2 years.  The prevalence of phantom pain in this 
sample was 72%. The Short Form-McGill Pain Questionnaire was used for descriptive analysis 
of the pain.  The six words that described phantom pain most often in the group were:  sharp 
(78%), tingling (77%), stabbing (72%), shooting (76%), throbbing (67%) and aching (56%).  The 
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authors suggested that future research needed to change from looking at prevalence to other 
factors affecting pain, such as disability or psychosocial aspects.  
Jensen et al. (2001) looked at descriptors of pain through categories.   The authors were 
testing a previously published classification of pain into the categories of mild, moderate and 
severe.  The authors found that this classification system did not work for phantom limb pain.  
Richardson et al. (2007) looked at the pain experience of those with phantom pain as 
multidimensional with various aspects affecting this pain type.  The authors conducted a 
prospective study looking at physical and psychological factors of pain in the lower extremity 
amputee that had this surgery due to severe peripheral vascular disease.  Phantom pain was found 
in 78.8% of the sample (n=59).   The psychological factor that was found to correlate with 
phantom pain was catastrophizing.  They also found that those that used the word “tender” as a 
descriptor of pain had a higher level of phantom pain at 6 months.  A limitation of this study is 
the small sample size. 
In a recent study by Clark et al. (2013) studying PLP and phantom sensations among a 
group of diabetes compared to non-diabetics, PLP descriptors were similar to those found by 
Ehde et al. (2000).  Prevalent descriptors of PLP were sharp/stabbing (47%), dull ache (34%), 
shooting/electric (33%), cramping (22%) and burning (17%) among the total sample of 88 
participants.  A limitation of the study was self-reporting since this was done by mailed 
questionnaire.    
Residual Limb Pain 
The second type of pain experienced after amputation is residual limb pain (RLP).  
Residual limb pain is any painful sensation that is localized to the remaining part of the limb 
(Wiffen et al., 2006).  RLP occurs with PLP after amputation but should be distinguished from 
	  	   26	  
this type of pain for treatment purposes (Behr et al., 2009; Flor, 2002; Dudgeon et al., 2005; 
Ephraim et al., 2005; Wiffen et al., 2006).  Reports of non-neuropathic or residual limb pain 
ranged from 32% to 74% (Ehde et al., 2000; Ephraim et al., 2005; Gallagher et al., 2001; 
Probstner et al., 2010; Smith, Comiskey & Ryall, 2008; Smith et al., 1999).  RLP is less often 
reported in the literature due to its similarity to postoperative pain.  A few studies reporting 
prevalence of RLP in the literature were found (Ephraim et al., 2005; Gallagher et al., 2001; 
Probstner et al., 2010; Smith et al., 2008).  Several studies looked at description of RLP by the 
amputee (Ehde et al., 2000; Ephraim et al., 2005; Dudgeon et al., 2005; Smith et al., 1999).  
 Prevalence.  Probstner et al. (2010) focused on the prevalence of pain in the amputee 
who had lost their limb due to cancer.   In this study, they found that RLP was 32%, which was a 
lower prevalence than other studies.  Limitations of this study were a small sample (n= 75) and 
lack of generalizability due to the study only taking place with cancer patients in Brazil.  Another  
study by Smith et al. (2008) measured RLP in lower extremity amputees in Ireland with various 
causes for the amputation (trauma, peripheral arterial disease and diabetes).  Prevalence of RLP 
in the sample (n= 107) was 56.1%.  The primary cause for the residual limb pain was prosthetic 
wear.  A correlation was made between RLP intensity and those that sustained the amputation 
due to a dysvascular cause.  A limitation of this study is generalizability of the sample.   
 The remaining four studies found a high rate of prevalence of RLP (Ehde et al., 2000; 
Ephraim et al., 2005; Gallagher et al., 2001; Smith et al., 1999).  Smith et al. (1999) found a high 
rate (76.1%) of RLP among a sample (n = 92) of primarily Caucasian, well-educated men.  In the 
study the authors found that RLP was as common as phantom pain and in some cases was worse 
than PLP.  Ehde et al. (2000) found a RLP prevalence rate of 74% in a sample (n = 188) that had 
similar characteristics of being primarily Caucasian, well-educated men. Ehde et al. came to the 
	  	   27	  
same conclusion as Smith et al., that RLP and PLP were equally prevalent.  A limitation of the 
Ehde et al. study is that it took place in the same geographic area as the Smith et al. study, which 
could have a sampling overlap between studies.   
 Gallagher et al. (2001) found a much lower rate of RLP (48.1%) in her sample (n=104).  
The study took place in Ireland and consisted of primarily males (75%).  The study did not 
include other demographics, such as education or ethnicity.   Forty-one percent of those 
experiencing residual pain reported that they experienced the pain two to five times per week. 
Another 22% experienced it 5 to 10 times per week and 13% had constant RLP. 
 Ephraim et al. (2005) completed a national cross sectional survey of prevalence of 
amputation pain.  The authors found that 67.7% of the sample experienced RLP. The sample was 
primarily white (85.8%), male (60.4%) and educated above high school level (93.8%).  Thirty-
eight percent of the sample had an amputation due to dysvascular causes.  After controlling for 
confounding variables, trauma patients were found to be 1.7 times more likely to have RLP than 
those that received an amputation for a dysvascular cause or due to cancer. 
 Descriptors.   The description of RLP is particularly important when trying to treat pain 
in the acute postoperative phase.  Two studies reported on the bothersomeness of RLP.  Smith et 
al. (1999) reported that RLP was more bothersome than phantom pain, but the intensity of both 
types of pain were the same.  Ephraim et al. (2005) also reported on bothersomeness of pain.  
More than half the sample (59.7%) reported RLP as somewhat bothersome and another 26.5% 
reported that it was extremely bothersome.  No other descriptive terms were used for RLP in 
these studies. 
 Dudgeon et al. (2005) in their mixed methods study used the McGill Pain Questionnaire 
(MPQ) to provide descriptors of RLP in a sample (n=1053) of disabled individuals.  The 
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objective of the study was to identify common pain descriptors and determine if the MPQ needed 
modification. Of those in the sample, 459 were amputees. The authors used a cluster analysis to 
list the frequency of descriptive words for each disability and to differentiate between 
musculoskeletal and neurogenic pain.  The three words most commonly clustered for amputees 
in describing neurogenic pain were shooting, sharp and stabbing.  The authors reported that the 
three words that were used in amputees for musculoskeletal description were aching, tight and 
tiring-exhausting.  The authors found that the MPQ needed modification to capture different 
types of pain and suggested a short form of the original instrument.    
 Ehde et al. (2000) in their cross-sectional survey of community-based lower limb 
amputees reported descriptors of amputation pain.  RLP was described by the sample as 
intermittent occurring one to six times a week.  The pain was reported as lasting from minutes to 
hours with a mean score of 5.4 (on 1-10 rating scale).  Thirty-eight percent of the sample 
reported severe intensity (7 to 10) during episodes of RLP.  RLP descriptors in the sample (n = 
255) included; aching, sharp, throbbing, hot-burning, tingling and shocking.  
Contextual Input Variables 
Patient Characteristics 
  Age.  Only three studies examined age in relation to amputation pain.  (Ephraim 
et al., 2005; Gallagher et al., 2001; Hanley et al., 2007).  Ephraim et al. (2005) reported the 
prevalence of pain type per demographic characteristics for her sample (n = 914).  Prevalence for 
each age group was similar for PLP in the 18-44, 45-54, 55-64 and 65 plus groups, with 
percentages of 78.3, 79.5, 83.9 and 79.0 respectively. RLP was also reported for the same age 
groups at 73.3% (18-44 years), 75.3% (45-54 years), 58.9% (55-64 years) and 54.1% (65 plus 
years). RLP was the only one that showed a decrease with the two older age groups.  Gallagher 
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et al. (2001) found conflicting results with age and PLP.  The authors found that participants 
reporting phantom pain were older than their younger counter part.   The sample for this study 
was much smaller than the Ephraim et al. study, which could cause a smaller effect size.  
 In the study by Hanley et al. (2006a) a reanalysis of two randomized control trials was 
completed to study the changes in chronic pain levels of two disabled groups, lower limb 
amputees and spinal cord injury patients.  The groups were randomly assigned to treatment 
groups of amitriptyline or an active placebo that were administered for six weeks.  They found a 
relationship between percent of meaningful change in pain scores and age.  Age had a significant 
positive correlation with change in pain scores with treatment.  Older individuals (42 years or 
greater) reported a better pain score with treatment than those that were younger.  A limitation of 
this study was the small sample size of amputees (n = 34).  Even though the study did find an 
association of pain and age for the overall group, the association of pain and age was not broken 
down into spinal cord injury patients and amputees.   
 Gender.  Four studies examined the relationship between phantom limb pain and gender 
(Bosmans et al., 2010; Ephraim et al., 2005; Gallagher et al., 2001; Hirsch, Dillworth, Ehde & 
Jensen, 2010).  Bosmans et al. (2010) and Gallagher et al. (2001) both found that women 
experience PLP more often than men.  Gallagher et al. reported that the prevalence of phantom 
pain in their sample (n = 104) was 87% for females (n = 26) and 67.1% for males (n = 78).  
Bosmans et al. did a regression analysis and reported that the odds for females (n=33) having 
phantom pain were 1.24 compared to males (n = 52). In both studies there were more males than 
females, which has been consistent throughout most amputation studies.   
 In comparing the prevalence of PLP and RLP with gender, Ephraim et al. (2005) found 
that both types of pain were similar in males and females. PLP for males and females was 80.4% 
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and 79.2% respectively within their study. RLP for males and females was 70.3% and 63.7% 
respectively.  In this study the sample was also predominantly male (60.4%).  
 Hirsh et al. (2010) also studied the moderating effects of gender on pain perception.  The 
study sample (n=335) primarily consisted of a large sample of men (72%), which is twice the 
percentage of women in the study.  The findings of this study were contrary to prior studies.  The 
authors found that males had a greater prevalence of phantom pain than females (86% vs. 77% 
respectively).  After controlling for limb loss, they found no statistical difference in reported 
pain. No differences were found among males and females in RLP , which has been supported by 
previous studies.  The authors did find a significant difference in overall pain and pain 
interference with females reporting greater pain overall and greater interference with pain in their 
daily activity level.  Limitations of the study were overrepresentation of men and a high 
percentage of Caucasian participants (92%).  In addition, men were more likely to be married 
than women (68% vs. 42%).  This difference was statistically significant.  Social support has 
been linked to pain differences and marital status may be a confounding variable in this study. 
 Education Level.   Two studies were found that examined education level as a variable 
associated with amputation pain.  Hanley et al. (2006b) found that the higher the educational 
level the less likely the amputee will seek treatment for pain.  They also found that a higher 
education level was not significantly associated with a lower pain level. The authors could not 
understand why the person would be in pain and not seek treatment.   This occurrence was not 
explored in their study.  Castillo et al. (2006) found that a lower education level was associated 
with higher pain in their study sample (n = 397).  The authors examined the impact of education 
on those patients experiencing the highest level of chronic pain (Chronic Pain IV).  They 
reported chronic pain IV for those with some college, those with a high school degree and those 
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with less than a high school degree.  Chronic pain was more prevalent (32%) in those with less 
than a high school degree when compared to those with a high school degree (15%) or some 
college (4%).  Limitations to generalizability in both studies are that the sample consisted of 
primarily Caucasian males with a higher level of education (high school graduate or above).   
The Castillo et al. study was longitudinal and had a dropout rate of approximately 29% over the 
seven years.   Those that were lost to follow up were less educated than the group that completed 
the study.   
 Race.  In the model presented, race is an included variable.  No studies were found 
examining race with amputation pain.  Studies that were found discussed the racial differences 
related to amputation rate. All studies reported that the rate of amputation is higher among 
African Americans compared to Caucasians  (Collins, Johnson, Henderson, Khuri & Daley, 
2002; Dillingham, Pezzin & MacKenzie, 2002; Feinglass, Rucker-Whitaker, Lindquist, 
McCarthy & Pearce, 2005; Peek, 2011, Resnick, Valsania & Phillips, 1999; Ziegler-Graham et 
al., 2008).  Dillingham et al. (2002) and Feinglass et al. (2005) both found that African 
Americans were two times more likely to have an amputation.  Collins et al. (2002) found that 
race was a risk factor for lower extremity amputation in people with peripheral vascular disease.  
African Americans and Hispanics are more likely to receive an amputation than Caucasians. 
However, most studies that have been discussed thus far had a representative sample of primarily 
Caucasian males (Ehde et al., 2000; Ephraim et al., 2005; Hanley et al., 2006a; Hanley et al., 
2007; Hirsch et al., 2010; Smith et al. 1999).  All but one of these studies took place in the 
Northwest region of the United States.   
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Clinical Characteristics. 
Surgical Procedure.   Four studies examined pain associated with the level of lower 
limb amputation (Bosmans et al., 2010; Ephraim et al., 2005; Gallagher et al., 2001; Hanley et 
al., 2007).  Bosmans et al. (2010) and Gallagher et al. (2001) found similar results in their 
studies.  The authors of each study reported that those individuals who had an above the knee 
amputation (AKA) have more PLP than those who have a below the knee amputation (BKA).  
Ephraim et al. (2005) found conflicting results in their study.  After controlling for confounding 
factors in the study, they reported that there was no statistical difference in prevalence of PLP 
and level of amputation.  Hanley et al. (2007) supported Ephraim’s study with results showing 
that there was no significant association of level of amputation in either PLP or RLP. A 
limitation of the Bosmans et al., Gallagher et al. and Hanley et al. studies is the small sample size 
in each.  Another limitation in the Hanley et al. study was that the findings were based on 
reanalysis of a previous study that had been done.  
 Cause.  There are different causes of amputation: trauma, chronic disease, congenital 
deformity and cancer.  Several studies reported PLP associated with cause or etiology for the 
amputation (Bosmans et al., 2010; Ephraim et al., 2005; Gallagher et al., 2001; Hanley et al., 
2007). Bosmans et al. (2010) and Hanley et al. (2007) found no association between cause and 
amputation pain.  The Ephraim et al. (2005) study included dysvascular, trauma and cancer 
related causes in their sample (n = 914).  They reported prevalence of PLP and RLP for each 
cause.  Phantom pain was highest in dysvascular patients (82.9%) when compared to trauma 
(81.2%) and cancer patients (73%). RLP was highest in the trauma group (74.8%) followed by 
the dysvascular group (65.3%) and lowest in the cancer group (59.7%).  However, after 
controlling for other factors, the authors concluded that etiology showed no statistical 
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relationship with pain.  The findings from this study did suggest that RLP was greater for trauma 
related amputations with likelihood that it would occur 1.7 times more in the trauma amputee.  
Gallagher et al. (2001) found that PLP varied depending on cause. The authors reported that 
85.7% of those that sustained an amputation due to a congenital condition did not experience 
phantom pain compared to those with cancer (12.5%), trauma (27.1%) and other causes (26.3%).  
The authors did not define “other” causes.  A limitation of the Gallagher study is that the sample 
consisted of a younger male population with the major cause of amputation being trauma. Both 
Hanley et al. and Bosmans et al. had small sample sizes.   
 Comorbidities.  Two studies linked chronic comorbid diseases with amputation pain 
(Gallagher et al., 2001; Ephraim et al. 2005).  Gallagher et al. (2001) found multiple comorbid 
diseases are associated with RLP.  They also found those experiencing phantom pain has more 
comorbidities than those without phantom pain (36.4% vs. 11%).  A limitation of this study is 
recall bias.  The study was a mailed survey asking patients to recall comorbidities at the time of 
surgery.  Another limitation is the sample is younger (45, mean age) and may not suffer from as 
many chronic diseases as those that are older. 
 Ephraim et al. (2005) showed an increase in both PLP and RLP in relation to the number 
of comorbid conditions.  Comorbidities increased the adjusted odds of phantom pain from a “not 
bothersome” state to an “extremely bothersome” state by 2.6 (95% CI, 1.0-6.4) for one comorbid 
state and up to 2.8 (95%, CI 1.2-6.7) for those with two or more conditions.  The same was found 
with RLP.  An adjusted odds ratio for residual pain was 2.2 (95%, CI 1.3-3.7) for participants 
with two or more comorbidities.   
 Anesthesia.  There have been limited studies related to the administration of anesthesia 
and amputation pain.  Three studies were found looking at route of anesthesia administration 
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(Lambert et al., 2001; Campbell et al., 2000; Ong, Arneja & Ong, 2006).  Campbell et al. (2000) 
completed a retrospective review of 349 charts of patients receiving a lower limb amputation 
over a seven-year period.  Anesthesia for this type of surgery was done by general anesthesia 
(55%) more often than by spinal (29%) or epidural (14%).  There was no statistical significance 
in mortality rate with types of anesthesia, however, the percentage of those receiving epidural 
anesthesia was higher (27%) compared to general (17%) or spinal (19%).  A limitation of the 
study was performing a retrospective chart review covering years 1992-1998 and the data only 
included one anesthesia practice.    
 Ong et al. (2006) evaluated pain levels of patients receiving epidural (54%), spinal (32%) 
and general anesthesia (32%) in a sample of 150 lower limb amputees. They found that after one 
week post-surgery the pain level was lower in those that received epidural and spinal anesthesia 
but it did not reach statistical significance.   During follow up at 14 months, there was no 
statistical difference in the amount of pain experienced.   The authors also found that at follow up 
phantom pain was frequent and severe regardless of whether the patient was on pharmacologic 
agents or not for this type of pain.  One major limitation of this study was that the data was 
gathered by recall when the participant returned to clinic.   
 Campbell et al. (2000) used general anesthesia and a perineural catheter on sixteen 
participants.  The catheter was inserted during surgery and was used to dose bupivacaine during 
the procedure and then infuse the medicine for up to 72 hours afterwards. RLP scores were 
statistically higher in the perineural group.  Phantom pain was also reported in this group but it 
did not reach statistical significance.  The small sample size limited this study.   
Prior Pain Control.  Presurgical pain control occurs during pre-hospitalization and is 
inclusive of the time spent in the hospital prior to surgery.  Most of the studies examining the 
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relationship of preoperative analgesia to postoperative pain were done using epidural 
administration of pain medication (Bach, Noreng & Tjellden, 1988; Karanikolas et al., 2011; 
Lambert et al., 2001; Nikolajsen, Ilkjaer, Christensen, Kroner & Jensen, 1997; Nikolajsen, 
Ilkjaer & Jensen, 1998).  Three of the studies used epidural administration of the analgesics 
bupivacaine and morphine (Bach et al, 1988; Lambert et al., 2001, Nikolajsen et al., 1997).  
Nikolajsen et al. (1998) used the same medications as the other three studies but used an 
extradural catheter instead of the typical epidural placement.  In all studies the medication was 
administered the day prior to surgery and then maintained during and after surgery.  In the three 
epidural studies and the one extradural study, the outcomes were all the same.  The conclusion of 
all the studies was that there was no effect on either PLP or RLP.   
 A study done by Karanikolas et al. (2011) used five analgesic regimens to investigate 
whether preoperative analgesia has an effect on PLP long term in four groups of randomized 
patients.  Medications used in the study were bupivacaine and fentanyl for the epidural 
administration and only fentanyl for the patient controlled analgesia (PCA).  All regimens used 
either preoperative epidural analgesia or preoperative PCA administration followed by either 
epidural anesthesia or general anesthesia in the operating room.  The study did find that pain was 
statistically better at six months if epidural or PCA analgesia was optimized preoperatively and 
for forty-eight hours postoperatively when compared to a control group that received normal 
analgesia and general anesthesia.  The result of this study varies from the previous studies that 
found no effects on long-term pain control.   
 Literature related to pain control pre-hospitalization is limited.  Ong et al. (2006) reported 
that only 58% of their sample (n=150) used an opioid for pain control prior to surgery.  Hanley et 
al. (2007) reported 56% of their sample had constant pain prior to surgery but did not mention 
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how it was controlled. Hanley et al. (2007) also found in their study that pre-amputation pain 
correlated with chronic phantom limb pain.  A limitation of both Hanley studies was secondary 
analysis of existing data.  Generalizability is also a limitation for Hanley since the studies were 
done with the same population.  The Ong et al. study had a larger sample with adequate 
measurement of preoperative medication.  
Anxiety and Depression 
Studies, which measure anxiety and depression, have shown that affective disorders can 
impact postoperative pain.  A number of studies have examined the influence of anxiety and/or 
depression on amputation pain (Cansever et al., 2003; Castillo et al., 2006; Chini & Boemer, 
2007; Darnall et al., 2005; Desmond & MacLachlan, 2006; Ephraim et al., 2005; Hawamdeh et 
al., 2008; Horgan & MacLachlan, 2004: Jensen et al., 2002; Kazemi et al., 2013; Liu, Williams, 
Liu & Chien, 2010; Price, 2005; Sherman, Gall & Gormly, 1979; Trame et al., 2008; Whyte & 
Niven, 2001).   
Anxiety 
Two studies measured anxiety alone in relation to amputation pain.  One study based the 
research on the pain-anxiety-tension cycle (Sherman et al., 1979).  The premise behind the study 
was that anxiety magnifies phantom pain in amputees by muscle tension in the residual limb.  
The authors felt that muscle tension feedback would decrease anxiety and subsequently pain.  
The sample (n=16) was supplied a muscle relaxation tape with exercises to perform when 
residual limb tension started, as well as, feedback of residual limb muscle tension.  Two of the 
participants were new amputees and the remaining sample was experiencing chronic pain from 
their amputation.  Fourteen patients out of the sample showed complete to significant pain relief.  
Follow-up of the sample showed sustained pain relief at six months and up to three years.  While 
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this study is dated and has a small sample, the results of this type of complementary therapy that 
can be self administered and is cost effective shows that these interventions are needed in the 
amputee experiencing pain in the acute and chronic periods.   
 Trame et al. (2008) also looked at anxiety in the lower extremity amputee to see if the 
level of anxiety affected pain level in the sample (n=23).  Anxiety levels were measured 
preoperatively and postoperatively using the Beck Anxiety Inventory.  The authors found that 
there was no correlation between pain levels and anxiety level postoperatively.  The study was 
limited by sample size.  
Depression   
Multiple studies have focused only on depression in relation to amputation pain 
(Cansever et al., 2003; Chini & Boemer, 2007; Darnall et al., 2005; Ephraim et al., 2005; Jensen 
et al., 2002; Liu et al., 2010; Price, 2005; Whyte & Niven, 2001).  Two phenomenological 
studies looked at the lived experience of amputees in Latin America and Taiwan (Chini & 
Boemer, 2007; Liu et al., 2010).  Themes found in both studies related depression to pain.   
Cansever et al. (2003) found in a group of Turkish military men that depression was higher for 
those who sustained the amputation because of disease (51.4%) rather than those who had an 
amputation due to trauma (34.7%).   
 Three of the studies found that those experiencing PLP were more likely to have 
depressive symptoms than those who did not have PLP but the depression was linked to factors 
other than the pain experience (Jensen et al., 2002; Price, 2005; Whyte & Niven, 2001).  Jensen 
et al. (2002) found higher depression was predictive of adjustment to PLP. He also found that 
psychosocial factors were responsible for the experience of phantom pain and in order to control 
pain, these factors have to be addressed.  Price’s (2005) findings were similar to Jensen.  He 
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found that there is a large common variance between social experiences and depression.  He 
found that phantom pain was non-significant in depression for the amputee.  Whyte and Niven 
(2001) found that the depression was not linked to pain or psychosocial factors but was related to 
the physical disability experienced by the amputee.  All of these studies were limited by small 
sample size.   
  Darnall et al. (2005) found that pain was directly related to depression in the amputee.  
Darnall et al. reported in their cross-sectional study (n=914) that the prevalence of depression 
was 28.7%.  Persons in the study that described PLP as extremely bothersome were 2.92 times 
more likely to have depression.  Those that reported that their RLP was extremely bothersome 
were 4.78 times more likely to have depression if between the ages of 18-54 years old.  The 
study also found that 32.9% of those with significant depression reported not receiving any 
treatment.  The group concluded that depression is common and often not properly treated.  The 
study by Ephraim et al. (2005) was done on the same sample as the Darnall study.  The 
conclusion about depression and pain for this study was the same in that depression and pain is 
correlation and that treating the depression may also assist in treating the pain. The limitation is 
that both published studies are identical in sample and findings.  The sample is limited in that it 
is predominantly made up of Caucasian males that are educated.  
Anxiety and Depression 
The majority of studies have measured both anxiety and depression simultaneously in the 
amputee population (Atherton & Robertson, 2006; Castillo et al., 2006; Coffey et al., 2009; 
Desmond & MacLachlan, 2006; Hawamdeh et al., 2008; Kazemi et al., 2013; Rybarczyk, 
Edwards & Behel, 2004; Singh et al., 2007; Singh et al., 2009).  
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 Prevalence.  Three studies reported anxiety and depression prevalence in the amputation 
population (Atherton & Robertson, 2006; Singh et al., 2007; Singh et al., 2009).  In the cross 
sectional study by Atherton and Robertson (2006), they reported prevalence rates of anxiety 
(29.9%) and depression (13.4%) in a sample of 67 amputees.   
Singh et al. (2007) measured prevalence of anxiety and depression after amputation and 
after inpatient rehabilitation in a convenience sample of 105 successive admissions of lower 
extremity amputees.   The authors found that at admission the depression and anxiety rates were 
26.7% and 24.8% respectively. At discharge from inpatient rehabilitation the rates dropped to 
3.8% and 4.8% respectively for depression and anxiety with a mean stay of 54 days.  The authors 
found that depression and anxiety were linked to a longer length of stay.  They found that 
depression was statistically significant in those with other medical comorbidities.  Anxiety was 
found to be higher in those living alone.   Singh did a second study that measured anxiety and 
depression after two to three years post hospitalization (Singh et al., 2009).  In this group (n=68) 
he measured a baseline anxiety and depression rate for both anxiety and depression on admission 
to the hospital and found a prevalence rate similar to his previous study (23.5%).   Singh et al. 
also found similar results at discharge from the initial hospital stay with a depression and anxiety 
rate of 2.9%.  The authors completed a follow up of the participants between years two and three.  
They found that depression and anxiety rates had approached baseline admission rates.  A rate of 
17.6% for depression and 19.1% for anxiety was found in the participants.  Depression, similar 
to the findings of the first study, was related to comorbid conditions. The authors also found that 
anxiety was higher among those participants that were younger. The authors could not explain 
why there had been an increase in prevalence after discharge.      
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Anxiety, Depression and Pain   
Hawamdeh et al. (2008), Coffey et al. (2009) and Kazemi et al. (2013) did not find an 
association among depression, anxiety and pain.  Hawamdeh et al. in their study on Jordanian 
amputees (n – 56) found 37% prevalence for anxiety and 20% prevalence for depression.  In this 
study, there was no difference in prevalence rates of anxiety and depression compared to similar 
groups in the United States (20% Jordanian vs. 28% in U.S studies).   Factors the authors found 
that correlated with depression and anxiety were being female, no social support, unemployment, 
traumatic cause, shorter time since amputation and having a below the knee amputation as 
compared to someone with an above the knee amputation.   
Coffey et al. (2009) measured anxiety and depression in a group (n=38) of diabetic 
amputees.   The authors found a prevalence of over 18% for anxiety and depression in this group.  
Anxiety was correlated with depression and body image in this study.  Depression was correlated 
with body image only. The authors found no correlation of these affective disorders and pain 
experienced by the sample. 
Kazemi et al. (2013) likewise found no association between depression and anxiety in the 
PLP patient compared to non-phantom chronic pain patients.  The authors used the Hospital 
Anxiety and Depression Scale (HADS) to measure anxiety and depression in 16 PLP patients 
and 24 non-phantom patients in an all male sample in Iran. The sample consisted of upper and 
lower amputations that had sustained limb loss due to trauma. Prevalence of anxiety and 
depression were found to be lower in the PLP group as compared to the chronic pain group.  
Limitations of this study included an all male sample, small sample size and generalizability.  
 Two studies have shown an association between the pain experienced after amputation 
and affective distress.  Castillo et al. (2006) evaluated secondary data from a larger multi-center 
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study comparing limb salvage patients to those sustaining an amputation.  The authors did find 
that elevated levels of anxiety and depression at three months after discharge from having an 
amputation is a strong predictor for chronic phantom pain seven years later.  Desmond and 
MacLachlan’s (2006) study supports Castillo et al.  They found in a sample of older men (n = 
582) a prevalence rate of 32% and 34% respectively for depression and anxiety.  Phantom and 
residual limb pain was reported by approximately 88% of the sample.  Of significance in the 
study was that depression was associated with elevated residual limb pain.  Limitations of the 
study included generalizability since the sample was all males.  The sample consisted of 
traumatic limb amputees suffering from posttraumatic stress disorder sustained in the war.  
Coping Strategies: Adaptation to Pain 
 Research on coping strategies or adaptation to amputation pain is limited.  Halbert, Crotty 
and Cameron (2002) performed a systematic review of the literature to examine the studies done 
on optimal management of acute and chronic phantom pain.  The researchers used Medline for 
the search, which included years of 1966-1996.  Studies that included a control group and 
distinguished phantom and residual limb pain as separate were included in this review.  Twelve 
studies met the criteria. They found 8 studies focusing on acute pain and 4 on chronic pain. The 
eight trials on acute pain used treatments of epidural medication administration (3), nerve blocks 
(3), treatment with calcitonin (1) and transcutaneous electrical nerve stimulation (TENS)(1). The 
four trials reported on chronic amputation pain used TENS (2), electromagnetic stocking (1) and 
ketamine (1).  No significance was found in any of the trials. The authors felt that the studies 
were contradictory and poorly randomized without supporting evidence for treatment in phantom 
limb pain whether acute or chronic.  
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Pharmacologic Therapy   
Opioid medication has long been the standard for pain relief after amputation surgery 
(Ehde & Smith, 2004; Huang & Kuiken, 2004).  Narcotic administration in the immediate 
postoperative period is suggested by amputation guidelines (Veterans 
Administration/Department of Defense [VA/DoD], 2007).  Opioids fail to work at the site of 
pain but work within the brain to numb the sensation (Ehde & Smith, 2004).  Despite the number 
of amputations that have been performed over a multitude of years, few interventional studies 
can be found that look at the effects of opioids on residual and phantom limb pain.  
Interventional studies found in the literature researched drug use of systemic anesthetics, local 
anesthetics, opioids, anticonvulsants and tricyclic antidepressants in the amputation population.   
 Systemic Anesthetics.  Three randomized control trials examined the use of ketamine 
during and after surgery for residual and phantom pain (Eichenberger et al. 2008; Hayes, 
Armstong-Brown & Burstal, 2004; Wilson, Nimmo, Fleetwood-Walker & Colvin, 2008).  
Ketamine, which is classified as a systemic anesthetic, was used for its effects on the opioid 
receptor sites.  Wilson et al. (2008) delivered the medicine through an epidural, while Hayes et 
al. (2004) delivered it intravenous.  The results of both of these studies showed no statistical 
difference between groups treated with the drug and a control group immediately after surgery, 
at 6 months and then again at 12 months.  Limitations of both studies were the small ample size. 
 Eichenberger et al. (2008) compared ketamine to placebo, calcitonin and a combination 
of ketamine and calcitonin in a double blind crossover study of chronic phantom pain (n=20).   
Medications were delivered intravenous on four separate occasions with intensity of pain 
recorded by a visual analog scale before, during, immediately after and after forty-eight hours.  
The main outcome of the study was a significant difference in pain intensity with ketamine alone 
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and ketamine in combination with calcitonin.  No difference in pain was seen in the calcitonin 
alone administration as compared to placebo.  A major limitation of the study was the small 
sample size.   
 Local Anesthetics.  Madabhushi, Reuben, Steinberg and Adesioye (2007) used the local 
anesthetic, bupivacaine in a case study to describe the effects on phantom limb and residual limb 
pain.  In the case presented the patient underwent general anesthesia.  Prior to transection of the 
tissues the authors infused bupivacaine and clonidine into the sciatic nerve. After nerve 
transection, the nerve was rotated at an angle and exposed through the skin.  The nerve was 
injected with a bolus of the bupivacaine and clonidine.  A continuous infusion of the mixture was 
started in the nerve and maintained for 96 hours postoperatively.  The mean pain score after 
surgery was 1.2 on a 1-10 scale.  The only required pain medication after surgery was 10 
milligrams of oxycodone. The patient was followed for one year postoperative with reports of no 
residual or phantom pain.   
Borghi et al. (2010) used a convenience sample of 71 patients undergoing lower limb 
amputation to infuse ropivacaine into a perineural catheter.   Participants were evaluated the first 
postoperative day and then weekly for four weeks and again at three, six, nine and twelve 
months.  The catheter infusion was turned off prior to survey administration, at which point the 
pain was rated on a pain scale of 0-4.  If the score was greater than 1 then the infusion was 
restarted.  Some infusions lasted long term (up to 83 days).   Mean infusion time was 30 days 
with 73% of the participants reporting intolerable pain on the first postoperative day. Pain scores 
after 12 months had fallen into the 0 to 1 category for overall pain.  However, at the one-year 
period 39% of the patients were still experiencing phantom limb pain.  A limitation of this study 
was lack of randomization and a control group.  
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 Opioids.  Four studies tested the effects of opioids on phantom limb pain in the amputee 
patient (Huse, Larbig, Flor & Birbaumer, 2001;Wilder-Smith, Hill & Laurent, 2005; Wu et al., 
2002; Wu et al., 2008) 
 Huse et al. (2001) tested the efficacy of oral morphine against a placebo in a double blind 
crossover study with a four-week washout period on 12 patients.  Measurement of pain included 
intensity, sensory level and affective descriptive level.  Patients receiving morphine had 
significantly lower pain, intensity, sensory and affective perception related to pain when 
compared to the placebo group.  A secondary aim of the study was to look at cortical 
reorganization using neuromagnetic imaging.  Only three participants could participate in the 
imaging.  Two of the three with high pain intensity did show cortical reorganization, while the 
third, which had less pain intensity, showed no reorganization.   The limitations of the study 
were a small sample size and lack of power of the study.  
 Wu et al. (2002) used a randomized double blind active placebo controlled cross over 
trial to study the effects of morphine and lidocaine on amputation pain.  A combination of 
lidocaine, morphine and diphenhydramine was used to formulate six variations of intravenous 
treatment.  The purpose of the study was to see if opioids are better than anesthetics for 
postoperative pain control after amputation.  The study found that morphine and lidocaine 
provided better relief for residual limb pain after surgery.  They also found that morphine was 
the better drug for relieving phantom limb pain.  The authors completed a power analysis prior to 
the study based on pilot data and found that 32 participants were needed to obtain power in order 
to obtain a 20% change in pain from baseline.  Participants in the study were only 31, which 
failed to obtain power for the study.  Another limitation of the study was that this was done with 
chronic pain patients.  The median time since amputation was five years.  The participants were 
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brought back to the hospital to implement this study.  Wu et al. (2008) conducted a second study 
using a double blind placebo controlled crossover design to study morphine versus mexiletine for 
chronic postamputation pain.  Participants treated with morphine had better pain control when 
compared to those treated with mexiletine or a placebo.   Although, the authors did report that 
morphine caused higher rates of side effects.  
 Wilder-Smith et al. (2005) randomized 94 participants into three arms of a randomized 
clinical trial.  The participants received tramadol, amitriptyline or a placebo.  If they were found 
to be nonresponders to tramadol (pain decreased by less than 10 on a visual analog scale), a wash 
out period was performed and they were placed in the amitriptyline group and vice versa.  The 
study showed no statistical difference in baseline intensity of phantom or residual pain, but did 
show an overall decrease in mean pain scores after one month of treatment for both the tramadol 
and amitriptyline group.  A limitation of this study is that the sample is not generalizable due to 
the majority of the population being male (n=84).  The study did meet power calculations for 
sample size.  
 Anticonvulsants.  Several studies were found that examined the effects of the 
anticonvulsant drug Gabapentin on postamputation pain (Bone, Critchley & Buggy, 2002; 
Nikolajsen et al., 2006; Smith et al., 2005).  Nikolajsen et al. (2006) performed a randomized 
control trial (n = 41) starting the Gabapentin on postoperative day one and continuing for 30 
days.  The max dose received by the participants was 2400 mg daily.  The control group received 
a placebo.  The study showed no statistical relationship between the drug and pain level at 30 
days and up to 6 months after surgery.  Limitations of this study were a small sample size, a slow 
titration schedule and pain intensity lower than normal.  Bone et al. and Smith et al. completed 
double blind cross over studies with wash out periods comparing Gabapentin to a placebo.  The 
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period of washout was different for each study with Smith et al. having a five-week washout and 
Bone et al. having a one-week washout.  The amount of drug was also different in each study.  
Smith et al. titrated up to 3600 milligrams a day while Bone et al. titrated only to 2400 
milligrams per day.  Smith et al. found that there was no statistical difference in pain between 
Gabapentin and placebo groups on a pain numerical rating scale.  Bone’s findings were different.  
Bone et al. found that after six weeks Gabapentin controlled phantom pain better than placebo as 
measured by a visual analog scale.  The difference in the results could be in the amount of time 
for washout, amount of maximum drug used or difference between scales. Limitation of both 
studies was a small sample size.  
 Tricyclic Antidepressants.  Two studies were found using the tricyclic antidepressant, 
amitriptyline to treat amputation pain.  Robinson et al. (2004) studied the effects of amitriptyline 
versus an active placebo after a six-week administration.  They found no significant difference in 
pain levels between groups.  Depression was a secondary outcome of the study with no reported 
difference.  Wilder-Smith et al. (2005) studied pain response as part of a placebo-controlled 
randomized three-arm trial.  The three groups were randomized to either a group receiving 
tramadol, amitriptyline or placebo.  The participants (n = 94) were considered treatment naïve 
since they had not received analgesics prior to the study.  Both tramadol and amitriptyline did 
not reach significance for control of both phantom and residual limb pain when compared to the 
placebo group, but did show an overall decrease in pain mean scores after one month of therapy. 
Non-Pharmacologic Therapy   
Coping with pain has primarily been viewed as a one-treatment approach with medication 
as the primary therapy.  Another treatment choice for pain control is non-pharmacologic therapy 
as a primary therapy or as a complementary therapy.   Although it is not widely recognized 
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within the medical community, literature does support the use of these therapies for pain relief 
(Ellis, 2002; Flor, 2002, Gatlin & Shulmeister, 2007; Nikolajsen & Jensen, 2001).  
Nonpharmacologic therapy works differently from pharmacologic therapy in that the goal is to 
decrease the perception of pain by increasing tolerance, decreasing intensity and increasing 
adaptive behavior (Gaitlin & Shulmeister, 2007).  With amputation pain, adaptation is important 
due to the projected chronic nature of this pain.  Nonpharmacologic therapy may help to reduce 
the intensity of the pain and increase tolerance by using this as a complementary therapy with the 
traditional pain control methods after amputation.  Richardson (2008) and Ketz (2008) discuss 
the need for nursing to use complementary therapy for pain control for amputees. Several forms 
of non-pharmacologic therapies were found in the literature being used with amputees for pain 
control.  None of these studies were randomized trials.  Therapies reported in the literature 
included acupuncture, reflexology, transcutaneous electrical nerve stimulation (TENS), mirror 
therapy and desensitization.  
 Acupuncture.  Bradbrook (2004) describes three case studies using acupuncture for relief 
of phantom limb pain and phantom sensation.  The intact limb was used for the acupuncture 
treatment.  A visual analog scale measured outcome.  Two of the three cases noted a lower pain 
level immediately after treatment.  One case required three further treatments for relieve of pain 
and then remained pain free for two months during rehabilitation.  The second case had 
immediate relief of pain with the first treatment and required no further sessions during 
rehabilitation.     
 In a current case study, reported by Davies (2013), the author describes a case of a 45 
year-old man with PLP and phantom sensations 3 months after amputation of the right arm.  He 
	  	   48	  
underwent acupuncture sessions on the contralateral arm with complete relief of PLP after seven 
sessions. The subject was three months post surgery.  
  Reflexology.  Brown and Lido’s (2008) pilot study (n=10) measured the effects of 
reflexology on phantom pain. Reflexology was performed on the intact leg and the ipsilateral 
(same side as amputation) hand.  The treatment was taught to the patient for self-administration.  
Pain level and pain duration was significantly lower during the treatment phases compared to 
phases when the therapy was not performed. Follow up was done at 12 months.  All participants 
continued to have a reduction of phantom pain with 67% of the participants continuing to self-
administer.  A limitation of the study was the small sample size. 
 Transcutaneous Electrical Nerve Stimulation (TENS).  TENS is often used as treatment 
for pain that is associated with a nerve conduction disorder.  Mulvey, Bagnall, Johnson and 
Marchant (2010) performed a systematic review of the use of TENS for phantom and residual 
limb pain after surgery in adults.  The authors found no randomized control trials among fourteen 
studies meeting criteria.  The fourteen studies consisted of primarily case studies with two 
studies that were nonrandomized.  In these cases there was no consistent outcome.  The authors 
concluded that there was an inability to claim effectiveness in amputation pain with TENS. 
 Since publishing the above systematic review, the authors have completed a pilot study 
using TENS to study the effect on phantom pain and residual limb pain at rest and with 
movement on a sample of ten lower extremity amputees (Mulvey, et al., 2013).  TENS therapy 
was applied for one hour.  Mean pain scores were reduced at rest and during movement.  The 
study was only a pilot and the authors suggested a follow-up feasibility study. 
 Mirror Therapy.  Mirror therapy is a relatively new therapy used as an intervention to 
help with pain in persons who are unable to move one extremity or having an absence of that 
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extremity with associated pain.  The therapy is based on sensory feedback of seeing two 
functional limbs with the help of a mirror.  A systematic review by Rothgangel, Braun, 
Beurskens, Seitz and Wade (2011) included ten randomized trials, seven series reports and four 
case studies.  Patients who suffered strokes, amputation and complex regional pain syndrome 
were included.  Two of the ten randomized trial studies pertained to phantom limb pain 
experienced by amputees.  The authors found that most studies were small and had limited 
evidence for conclusive findings.  Another concern was the lack of details related to treatment 
and side effects.   
 A study done by Darnall and Li (2012) related to mirror therapy used a prospective 
design for a pilot study on forty community dwelling amputees with phantom pain to test pain 
intensity using mirror therapy. The therapy was self administered at home.  Pain intensity was 
significantly reduced one month and again at two months.  The authors also found that higher 
educated participants had a greater pain intensity reduction.   Casale, Damiani and Rosati (2009) 
questioned the ethics in using this therapy.  They retrospectively reviewed side effects and 
adverse outcomes of thirty-three patients who received mirror therapy and found twenty-five 
with side effects which included confusion, dizziness and irritation.  Four refused to continue the 
treatment.  Only four participants had no complaints.  The conclusion was that patient selection 
should be more structured for studies with this therapy.  
    Desensitization. Desensitization is a form of non-pharmacologic therapy.  
Conceptually, desensitization is defined as a technique of massage and tapping of the residual 
limb beginning the first day after surgery to help reduce and control pain through self 
management  (Huang & Kuiken, 2004; VA/DoD, 2007).  Although no formal research literature 
was found using desensitization to control amputation pain, Atkins (2004) describes the 
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technique as a needed skill for two reasons.  First, the patient knows their tolerance to the 
therapy and can easily administer it based on their own comfort level.  Second, the patient 
becomes accustomed to their body after surgery.  Huang and Kuiken (2004) describe the 
technique as assisting with pain by affecting the gate control mechanism.  The benefits of using 
this technique are pain control, establishment of body image and psychological adjustment 
(Huang & Kuiken, 2004).  Clinical practice guidelines for the care of the amputation patient have 
been established through the Agency of HealthCare Quality Research (VA/DoD, 2007).  These 
guidelines recommend narcotics immediately after surgery with the addition of other 
nonpharmacologic measures, including desensitization. The guidelines not only refer to the 
technique as a pain modulator but also discuss using the technique to help with body image 
adjustment.  No protocol or randomized trials were found in the literature using this as a 
complementary therapy in acute or chronic amputation pain.  
Application of Models 
Roy’s Adaptation Model 
Roy’s’ Adaptation Model supports the premise of this study by providing a 
complementary therapy in the adaptation to amputation pain in order to establish a holistic 
environment after surgery.  The model is based on the sensory aspect of the pain experience.     
Roy’s Adaptation Model has been used in a number of various settings, including practice, 
education and research.  The model has also been used to develop research instruments, as well 
as, middle range theories (Ducharme, Ricard, Duquette, Levesque & Lachance, 1998; Dunn, 
2004; Levesque, Ricard, Ducharme, Duquette, & Bonin, 1998; Newman, 1997; Tsai, Tak, Moore 
& Palencia, 2003).  The extensive use of the model shows its adaptability to assist in helping the 
patient adapt with nursing practice.  
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 However, only one study was found in the literature that used the Roy Adaptation Model 
with amputation patients.  Santarlasci (2009) used the model to measure the relationships of pain, 
functional ability, depression and social support with coping and returning to work for lower 
extremity amputees in her dissertation.  A secondary purpose of the study was to measure 
interrelatedness of the concepts for congruency with Roy’s model.  The author was unable to 
perform a path analysis to measure interrelatedness.  She did find relationships with pain and 
depression and pain and functional ability during the process of coping or trying to adapt to their 
situation.  
Neuromatrix Theory   
The Neuromatrix theory is described by Melzack (1999) as going beyond the pain gate 
theory to explain how an individual perceives pain in the brain when there is no apparent sensory 
input, such as from a phantom limb. One study was found that used Melzack’s Neuromatrix 
theory to study phantom limb pain.  Pucher, Kickinger and Frischenschlager (1999) performed 
an empirical-diagnostic study looking at coping with limb loss, body image and phantom pain 
based on Melzack’s Neuromatrix theory.  The authors interviewed a sample of 43 amputees that 
were divided into two groups, those with phantom pain and those without pain for coping 
strategies. Body image was evaluated by drawing pictures of their body after the amputation.  
The authors found that coping with loss and lack of complaints was positively correlated.  The 
cognitive image portrayed by drawing correlated with suffering from phantom pain.  If the 
person drew himself or herself intact then they suffered more than those that did not.  The 
correlation between coping by psychological adjustment of the patient and neuronal adjustment 
of the cognitive process supports the neuromatrix principal of modification of the pathway.
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 In this study, the Roy Adaptation Model fits well within the adaptation of the amputee in 
the acute setting following surgery.  The patient is attempting to adapt to a number of unfamiliar 
experiences after surgery. However, the first stimulus the amputee must cope with is the pain 
experienced after the surgery.  The only way for adaptation to continue within this population is 
to alleviate the focal stimulus.  The process of adaptation to amputation pain is both a 
physiological and psychological process.  Understanding how to interrupt the physiological 
process of the pain pathway is needed in order to cope.  Without relief from pain, rehabilitation 
and adaptation cannot proceed.  The patient will then enter a compromised state without 
adequate pain measures.  
Summary 
 Pertinent literature related to the variables in this study was presented in this chapter.  
Pain is the focal stimulus of the person recovering from an amputation.  The literature has given 
prevalence rates of residual limb pain and phantom limb pain.   Phantom limb pain has been 
reported occurring in between 63% to 84% of those with an amputation years after the surgery.  
Residual limb pain is reported at prevalence rates of 32% to 74% after surgery.  Residual limb 
pain can be chronic but is less likely than phantom limb pain to continue in a chronic state.  
Literature has also reported descriptors of the two types of pain to help distinguish between 
them.  This is important when attempting to treat the pain.  Descriptors for phantom pain 
included sharp, tingling, stabbing, shooting, burning and stinging.  Descriptors used in residual 
limb pain were aching, tight, throbbing and bothersome.  
 The focal stimulus of pain is often heightened by contextual factors, which can be related 
to demographics, clinical characteristics or affective distress.   Demographics (age and gender) 
showed mixed results related to their effect on pain.  Although two out of the three studies 
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reported that women had a higher rate of pain, it is uncertain if this is because women seek 
treatment and are more open than men about their pain.  Education level was seen as a factor in 
chronic pain. Those with lower educational levels tend to report chronic pain after amputation 
years after the initial surgery.  A gap in demographics was found in race and amputation pain.  
Although, no studies reported a correlation between the two variables, it was found that African 
Americans are twice as likely of having an amputation related to diabetes or peripheral arterial 
disease.   This is an important aspect in research related to amputation pain since a majority of 
the reviewed studies had predominately Caucasian participants.  
 Clinical characteristics that have been studied in association with amputation pain are 
surgical procedure type, cause of amputation, comorbidities and anesthesia used.  The type of 
surgical procedure type made no difference in the amount of pain experienced by the amputee.  
Cause did seem to be a contributing factor.  Those that lost a limb due to a congenital factor had 
less pain when compared to those who had an amputation due to a dysvascular condition or 
trauma.  Comorbidities significantly affected the amount of pain the amputation patient 
experienced.  A correlation was found between comorbid conditions and reported pain.  Type of 
anesthesia used during the surgical procedure had no effect on pain experienced after surgery.   
 Pre-surgical pain control, anxiety and depression have been identified as possible 
contributing factors to the experience of pain after amputation.  Pre-surgical pain control 
interventions that have been studied have been centered on the use of epidural administration for 
pain control.  The majority of the studies found no significance difference in pain control using 
an epidural.  The literature did not report pain control pre-hospitalization but did find a lack of 
overall optimization of pain control in the amputee.  Depression and anxiety have been found to 
have a higher prevalence rate in the amputation population when compared to the general 
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population.  Studies have found mixed results on whether anxiety and depression are related to 
amputation pain experienced after surgery.     
 Coping strategies for amputation pain have centered on the use of pharmacologic agents 
with minimal studies done using non-pharmacologic methods.  A limited number of studies were 
found that used complementary therapy in treating this type of pain.  Pharmacologic studies have 
focused on several classes of drugs:  systemic anesthetics, local anesthetics, opioids, tricyclic 
antidepressants and anticonvulsants.  Most of the studies have had mixed results.   The use of 
morphine has shown the best effect for the relief of amputation pain.  The studies using 
morphine were done on samples that were experiencing chronic pain.   The anticonvulsant, 
Gabapentin has been used in the relief of phantom pain.  The studies completed thus far have 
shown no significance with amputation pain and its use.   
 Non-pharmacologic therapy has been reported as case studies or has been nonrandomized 
studies.   Desensitization is a non-pharmacologic therapy that has been extensively taught in 
nursing and allied health as a pain relief measure for this population.  The technique is also 
described in clinical practice guidelines on the care of the amputation patient.  No research could 
be found that supported the use of the technique in pain control. 
 Most studies were methodologically limited and provided information into the 
complexity of amputation pain.  However, two areas in the literature are void of information.  
One of the gaps in the literature relates to the patient characteristic of race and amputation pain.  
Most studies reported a representative sample of Caucasian males.  These studies have primarily 
been done in the Northwest United States.   It is important to understand the differences in pain 
experience among races for efficacious treatment.  A gap is also found in the use of 
nonpharmacologic therapies as a technique to control pain in the postoperative setting either as a 
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stand alone or complementary therapy.  Desensitization is theoretically supported in the literature 
as a pain relief complementary measure, although, there is no supporting research evidence 
found for this technique.   
 Due to limited complementary therapy studies and seeing the complexity of amputation 
pain, this pilot study on the use of desensitization as a complementary measure in controlling 
amputation pain in the acute care setting was designed to explore this topic.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
CHAPTER 3:  RESEARCH METHOD AND DESIGN 
This pilot study tested the feasibility and efficacy of a desensitization protocol in 
hospitalized amputees in the immediate postoperative period.  This chapter will discuss sample, 
setting, instruments, measurement, data collection and the data analysis procedure.  
Research Design 
 The study used a prospective repeated measure design to test the feasibility of using 
desensitization in the person who had received a major lower limb amputation.  The participants 
were taught a desensitization protocol after surgery.  The normal pharmacological pain regimen 
was administered as ordered by the physician and when requested by the participants during the 
study. 
Setting and Sample 
  The facility where the study took place is comprised of an 850-bed academic tertiary care 
facility in the Eastern United States with non-acute, intermediate and acute beds.  It is part of a 
larger multihospital system and receives patients from twenty-nine counties surrounding the 
immediate area.  Referrals for amputation surgery are received from all twenty-nine counties.  
The facility has an associated acute rehabilitation center attached to the main hospital.  The 
rehabilitation center is a 75-bed inpatient facility.  The rehabilitation center admits spinal cord 
injury, traumatic brain injury, stroke and general rehabilitation patients.  A majority of new 
amputees are admitted to the general rehabilitation population after spending approximately six 
days in the acute setting.  Approximately 55% of patients that have amputation surgery transfer 
to the rehabilitation facility.  Of the remaining amputee patients, 10% are discharged to home 
with home health and outpatient referral for rehabilitation, 20% return to a skilled facility where 
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they previously resided, 10% require new skilled facility placement after surgery and 5% are 
moved to a rehabilitation facility nearer to their place of residence.   
 One academic surgical practice specializing in vascular surgery receives 95% of patients 
referred for an amputation with a diagnosis of a dysvascular condition.  The surgical practice is 
comprised of four attending surgeons, four residents and two physician assistants.  The practice 
holds clinic four days per week with one attending in clinic each of those days.   	   The surgical group admits amputation patients primarily to one intermediate unit after 
surgery. The intermediate unit is a 32-bed unit that specializes in the postoperative care of the 
vascular surgery and cardiac surgery patient. The unit is staffed with a 4 (patients) to 1 (nurse) 
ratio. Physical therapists and occupational therapists are available by a consult on the unit.  A 
physical therapy, occupational therapy and rehabilitation consult are usually completed on 
patients that have the potential to go through a full rehabilitation and that are not from a skilled 
nursing facility.  An electronic medical record is used for patient charting. The unit does allow 
two family members to stay with the patient at all times.  Visitation by other family and friends 
can occur any time during the day until evening.    
 The study sample consisted of participants that had an amputation by the vascular surgery 
group with a primary cause of peripheral vascular disease, diabetes and/or end stage renal 
disease (ESRD). A convenience sample was used that met inclusion criteria.  Inclusion criteria 
for the study were:  1) 18 years of age or older 2) participants must be able to understand and 
speak English 3) mental capacity to participate in using the protocol 4) receiving a lower 
extremity amputation due to a dysvascular cause.  Exclusion criteria were: 1) amputations caused 
by trauma 2) partial foot, toe or arm amputations 3) non-English speaking 4) diagnosed mental 
illness or drug addiction.  Trauma patients that have an amputation were excluded due to 
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variation in pain protocols with this population.  A sample size of 30 participants was projected 
for the study, but due to exclusion criteria and research recruitment difficulties this sample size 
was not reached in this pilot study.   
Study Approval 
 The principal investigator received support from the Director of Nursing Research at the 
facility where the research was conducted.  Once support was obtained, submission to the 
University and Medical Center Institutional Review Board (UMCIRB) was submitted and 
approved.  See Appendix A.  
Data Collection and Instrumentation 
 Data collection consisted of a general demographic and clinical questionnaire, Short 
Form McGill Pain Questionnaire-2 (SF-MPQ-2), Hospital Anxiety and Depression scale 
(HADS), intervention journal card for recording times desensitization used, intervention 
questionnaire and feasibility questionnaire.  
 The general demographic questionnaire consisted of information related to age, gender, 
race and educational level.  Chart reviews were completed to determine clinical characteristics 
related to the surgery including type of procedure, comorbidities, cause of amputation and 
anesthesia type.  Type of procedure was classified as above the knee amputation, below the knee 
amputation or knee disarticulation.  Comorbid conditions included cardiac disease, peripheral 
vascular disease including aneurysm and carotid disease, chronic lung problems, hypertension, 
diabetes and history of amputation with notation of underlying disease state of present 
amputation.  The chart review included information on operative induction.  Induction was 
classified as general, spinal or epidural.  Pain medication taken in the preoperative setting was 
collected, as well as, any interventions the patient used to relieve pain.  Pain medication in the 
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postoperative setting included drug, route and amount in milligrams each day after surgery until 
discharge or postoperative day six. Pain medication was converted using equianalgesic 
conversion in order to have a comparative analysis of amount.  The majority of participants 
received intravenous (IV) pain medication immediately after surgery for approximately two 
days.  The participants were usually switched to an oral opioid form after the initial two days.  
For some participants, administration of an IV pain medication for break through pain was 
ordered during the remainder of the hospitalization, if needed, after switching to the oral opioid.  
Conversion of the initial IV pain medication, as well as, any IV pain medication used for 
breakthrough pain was done by converting the IV milligrams of the opioid to oral milligrams of 
the primary opioid the participant was converted to after surgery.   
Feasibility was recorded with several measures. Intervention journal cards were left with 
the patient to record the number of times the patient used desensitization each day, pain level 
before and after and who performed the desensitization.  Verification that the protocol was being 
done correctly by the patient was measured using an intervention questionnaire that confirmed 
steps of the protocol. A feasibility survey was given to the patient for completion at the end of 
the acute care period, which measured ease of use, satisfaction with the procedure and perceived 
benefits.  
Revised Version of the Short-form McGill Pain Questionnaire (SF-MQP-2) 
 
 The SF-MPQ-2, developed and validated by Dworkin et al. (2009), was used to measure 
the quality of pain in the study subjects and consists of 22 pain descriptors with responses scaled 
from 0 (no pain) to 10 (worst possible pain).  On the basis of exploratory factor analyses, 
confirmatory factor analyses, and prior research on human pain, four SF-MQP-2 subscales were 
defined.  The subscales and their sensory descriptors include the following: (1) continuous pain 
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descriptors (6 items): ‘throbbing pain”, “cramping pain”, “gnawing pain”, “aching pain”, “heavy 
pain”, and “tender”;  (2) intermittent pain descriptors (6 items): “shooting pain”, “stabbing 
pain”, “sharp pain”, “splitting pain”, “electric-shock pain”, and “piercing”; (3) predominately 
neuropathic pain descriptors (6 items): “hot-burning pain”, “cold-freezing pain”, “pain caused 
by light touch”, “itching”, “tingling or pins and needles”, and “numbness”; and (4) affective 
descriptors (4 items): “tiring-exhausting”, “sickening”, “fearful”, and “punishing-cruel”.  The 
validation sample for the SF-MQP-2 consisted of 882 subjects who had experienced chronic pain 
for an average of over 8 years.  Internal reliability assessed with Cronbach’s alpha for the total 
score and four subscales are as follows: total score (α = 0.91); continuous pain (α = 0.73); 
intermittent pain (α = 0.85); neuropathic pain (α = 0.78); and affective descriptors (α = 0.77). 
Other Pain Measures 
 In addition to the SF-MPQ-2, a visual analog scale was used to measure the intensity of 
the patient’s current pain with scale endpoints of 0 = no pain and 10 = worst possible pain.  A 6-
point ordinal scale asked the patient to describe their current pain using the following response 
categories: 0 = no pain; 1 = discomforting; 3 = distressing; 4 = horrible; and 5 = excruciating.  A 
3-point ordinal scale asked the patient to describe the frequency of their current pain by selecting 
either the word brief, intermittent, or continuous. 
Hospital Anxiety and Depression Scale  
 The Hospital Anxiety and Depression Scale (HADS) is a patient-completed, 14-item 
scale, with seven items measuring anxiety and seven measuring depression on a 4-point (0 – 3) 
response scale.  Scores range from 0 to 21 for each scale with higher scores representing more 
distress.  Various cut off points have been proposed for indicating severity and consensus 
suggests a score of eight to ten (on each scale) to represent possible cases, 11 or more for definite 
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cases, and 14/15 to represent severe disorder (Bjelland, Dahl, Haung & Neckelman, 2002).  
Evidence of validity comes from correlating the HADS with other anxiety or depression 
instruments.  The Beck Depression Inventory and HADS depression had a correlation of .73, and 
HADS anxiety had a correlation of .71 with the State Trait Anxiety Inventory (Bjelland et al., 
2002).  Five studies used the HADS for research with lower extremity amputations (Coffey et al., 
2009; Desmond & MacLachlan, 2006; Hawamdeh et al., 2008; Singh et al., 2007; Singh et al., 
2009).  None of these studies reported internal consistency reliability for the scales.   
Intervention Journal Card 
 The participant recorded the time on each post-operative day that desensitization  
was self-administered along with pre-intervention and post-intervention pain level on a 11-point 
numerical scale (0-10) on the card. One card was designated for each postoperative day.  See 
Appendix C.	  	   	  
Intervention Questionnaire 
 The purpose of completing an intervention log questionnaire was to confirm that the 
participant knew how to administer the steps of the intervention and if it could be followed 
easily.  The principal investigator completed the log on repeated measure days after the 
intervention was taught.  The log was based on the protocol for administering desensitization that 
was created by the principal investigator. The protocol was developed based on a review of the 
literature and in consultation with physical therapists. Information was gathered from material 
related to desensitization, therapeutic clinical massage and dermatomes. The participant was 
asked if the knee immobilizer was removed, where the massage took place, if a circular massage 
pattern was used, the number of times massaged, if tapping was used and if there were any 
special areas that needed attention.  A picture of a limb was also available for the participant to 
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point to areas that were particularly painful and had to be massaged and tapped more often. See 
Appendix D for the Desensitization Protocol and Appendix E for the Intervention Questionnaire. 
Feasibility Questionnaire 
Feasibility was measured with a five-item questionnaire that also had an open comment 
at the end of the questionnaire for feedback about the intervention (See Appendix F).  The 
feasibility survey was given to the participant during postoperative day six or when the 
participant was discharged, if the participant was still available.  
Procedure 
 After IRB approval, the principal investigator (PI) met with staff and designated contacts 
in the clinic and hospital. The PI discussed enrollment procedures, inclusion/exclusion criteria 
and the study protocol. Advertisement flyers giving a brief description of the study were placed 
in a designated location within the hospital for staff to see. After three months of difficulty in 
recruitment, the PI met with the vascular surgery group in order to explain the study again and 
answer any questions.  During the discussion, a conflict was noted in consenting potential 
participants for this study prior to surgery due to another pain study currently enrolling 
amputation participants at the same time.  The group felt this was confusing to potential 
participants of this study.   After discussion of a feasible change in protocol, it was decided to 
change the day of consenting potential participants for this study to postoperative day two. It was 
felt that the participant could consent without any untoward effects of the anesthesia. No 
participants had been enrolled prior to this meeting, so a revision was made and submitted to the 
UMCIRB with approval.  Enrollment began after the revised protocol.  Notification of potential 
participants by the designated contacts within the hospital was done once the person had agreed 
to discuss the research.   
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  After notification, the PI met the patient on the second postoperative day to consent the 
participant, do baseline collection of the SF-MPQ-2 and HADS questionnaires, teach the 
desensitization technique and answer any questions.  After consent and baseline data was 
collected, the PI taught the desensitization protocol to the patient and any family that may be 
interested.  After instruction and a return demonstration by the patient, the PI left a patient 
teaching booklet on desensitization for the patient’s reference (See Appendix G).  The participant 
was supplied with the journal cards with instructions on recording times the desensitization was 
used, for how long, pain scores before and after use and who performed the intervention. 
The PI returned on postoperative day 4 and 6 to gather data on the SFMP-Q, the HADS, 
the intervention questionnaire and pick up any completed journal cards.  The participant was 
then re-instructed on the use and completion of the journal cards if the participants were not 
completing them.  The PI also answered any questions and reinforced the desensitization 
technique. On postoperative day 6, the Feasibility Questionnaire was completed with the 
participant.  The participant also was asked to share any comments about their experience using 
desensitization or the technique in general.  Due to early discharges and one withdrawal, not all 
participants completed the Feasibility Questionnaire. Retrieval of data on demographics, clinical 
characteristics and pain medication was collected by chart review during each visit. 
Data Analysis 
 All statistical analyses were completed with IBM SPSS version 20 after coding and 
entering into the system. Descriptive statistics including frequency, percentile, mean and 
standard deviation was used to describe the variables of the study. Psychometric properties of the 
SF-MPQ-2 and HADS were analyzed for reliability by Cronbach’s coefficient alpha. Correlation 
analysis was used to determine the strength and direction of variables including medication 
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dosages, continuous pain, intermittent pain, neuropathic pain, affective descriptors, anxiety and 
depression were completed using Spearman rho coefficient. Paired sample t-test was used to 
compare mean scores of the group on minutes intervention completed and pain difference before 
and after the intervention during repeated measure time frames.  Statistical significance level was 
set at a p value of <.05.   
Summary 
 This chapter has described the research design, sample, setting, instruments, data 
collection, human protection measures and data analysis plan completed in this study.  In this 
prospective repeated measure design, a convenience sample was used.  A newly constructed 
desensitization protocol was taught to participants in order to see if the technique met feasible 
and efficacious use and to explore any correlations among variables including pain, anxiety and 
depression while using the protocol. 
 
 
 
 
 
 
 
 
 
 
 
	  	  
Chapter 4:  FINDINGS 
In this chapter the findings of the study will be presented.  Before the findings related to 
each research question are presented, the internal consistency reliability of the SF-MPQ-1 and 
HADS are presented for the three measurement times. 
Instrument Characteristics 
 The internal consistency reliabilities (Cronbach’s alpha) for the SF-MPQ-2 total scores 
are all above .80.  As expected some of the subscales have reliabilities lower than the .70 
criterion because of the small number of pain descriptors associated with the subscale and not all 
the patients are expected to have experienced the same sensory, affective, and evaluative 
qualities of pain which result in low inter-item correlations.  The HADS anxiety and depression 
scales administered before postoperative day 6 also had lower reliabilities than expected.  This 
could be related to several items that were inappropriate to these patients in the immediate post-
operative period. For example, three of the anxiety statements asked if they were able to sit at 
ease and feel relaxed, looking forward with enjoyment to things, and being able to enjoy a good 
book, radio or television program.  Statements related to the depression subscale seen as 
problematic for this population were being able to laugh and see the funny side of things and 
losing interest in their appearance.  All of the skewness values showed there was not any marked 
skewness in any of the measures.  See Table 1.  
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Table 1 
Psychometric Properties of the Study Instruments 
 
      Cronbach’s 
Instrument   POD  Alpha         Skewness 
SF-MPQ-2     1 
    Continuous pain      .74      .85 
    Intermediate pain      .64    1.07 
    Neuropathic pain      .78      .39 
    Affective description     .55      .94 
    Total score       .90    1.18 
SF-MPQ-2     2 
    Continuous pain      .45      .53 
    Intermediate pain      .88    1.00 
    Neuropathic pain      .75    1.11 
    Affective description     .61    1.09 
    Total score       .88      .66 
SF-MPQ-2     3 
    Continuous pain      .67    1.05 
    Intermediate pain      .73      .41 
    Neuropathic pain      .38     -.49 
    Affective description     .84    1.52 
    Total score       .81      .16 
HADS     1 
    Anxiety       .63      .19 
    Depression       .42                -.04 
HADS     2 
    Anxiety       .62      .65 
    Depression       .79    1.25 
HADS     3 
    Anxiety       .85    1.34 
    Depression       .87    1.46 
Note.  POD = post-operative day.  SF-MPQ-2 = Short Form McGill Pain Questionnaire 2.  
HADS = Hospital Anxiety and Depression Scale. 
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Research Questions 
Research Question 1  
(1) What are the demographic (age, gender, ethnicity, education level) and clinical characteristics 
(type of amputation, reason for amputation, pre-amputation pain management) of the lower limb 
amputee patients in the study? 
Participants were considered for enrollment over eleven months.  Eleven of the patients 
refused enrollment with the primary reason being fatigue.  Of those that refused, most were men 
(82%) and African American (82%).  Another nineteen patients were excluded due to dementia, 
change in neurological status, medical emergency, another procedure being performed, system 
issues or healthcare power of attorney not present.  The final sample consisted of twelve enrolled 
participants.  One participant withdrew from the study on postoperative day four, before 
administering the surveys.  Two participants were discharged on postoperative day four and one 
on postoperative day five.  
The final sample (N = 12) consisted of predominantly African American (66.7%) females 
(58.3%) with less than a high school education (41.7%).  The ages of the participants ranged 
from 52 to 73 years (M = 60, SD = 7. 47).  The final sample included 7 females and 5 males.  
Two had some college, 1 was a college graduate, 4 were high school graduates, and 5 had less 
than a high school education. 
 Table 2 presents the clinical characteristics of the study sample.  Amputation rates were 
similar above or below the knee, with most amputations involving the right leg.  The reason for 
the amputations was primarily related to peripheral vascular disease (PVD) caused by diabetes.  
The most common comorbidities were hypertension, diabetes, and peripheral vascular disease.  
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Pain prior to surgery was controlled by oral opioids.  Almost all of the patients had general 
anesthesia. 
Table 2 
Clinical Characteristics (N = 12) 
Variable n % 
Amputation Level   
    Above Knee Amputation  5 41.7 
    Below Knee Amputation  6 50.0 
    Knee Disarticulation  1  8.3 
Side Amputated   
    Right  8 66.7 
    Left  4 33.3 
Cause of Amputation   
    PVD with Diabetes  8 66.7 
    Diabetes with ESRD  2 16.7 
    PVD only  1  8.3 
    PVD with ESRD  1  8.3 
Comorbidities   
    Hypertension 12 100 
    Diabetes 10 83.3 
    PVD 10 83.3 
    Coronary Artery Disease  4 33.3 
    COPD  3 25.0 
    ESRD  3 25.0 
    History of previous amputation  3 25.0 
Pain Control Before Surgery   
    Oxycodone 5- 325  8 66.7 
    Gabapentin  6 50.0 
    Tramadol  2 16.7 
    Flexeril  2 16.7 
    Roxicodone IR  1   8.3 
    Duragesic patch  1   8.3 
    Voltaren  1   8.3 
    Hydrocodone 5 -325  1   8.3 
Anesthesia   
    General 11 91.7 
    Spinal  1   8.3 
Note.  PVD = Peripheral Vascular Disease.  ESRD = End Stage Renal Disease.  COPD = 
Chronic Obstructive Pulmonary Disease 	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Research Question 2 
 2a.  What are the patterns of pain quality, total pain, type of pain, pain management (opioid use), 
anxiety and depression in the immediate post-operative period (POD 2, POD 4, POD 6)?   
Descriptive statistics for the SF-MPQ-2 total score, subscale scores, and pain and 
affective descriptors are summarized in Table 3 for the three measurement days.  At POD 2 the 
subscales of intermittent pain and affective description had the highest mean, with neuropathic 
and continuous pain having the lowest means.  The POD 2 pain descriptors with the highest 
intensity included sharp pain (M = 7.2), tiring-exhausting (M = 6.6), tender (M = 5.25), pain 
caused by light touch (M = 5.25), and piercing (M = 4.8).  By POD 6, all the pain measures had 
decreased with continuous pain showing the largest mean (M = 2.4).  At POD 6 the pain 
descriptors with the highest intensity included tender (M = 4.9), pain caused by light touch (M = 
4.25) and throbbing pain (M = 3.6).   
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Table 3 
 
Pattern of SF-MPQ-2 Pain Types and Associated Sensory and Affective Descriptors at Post-
Operative Day 2, 4 and 6 
 
     POD 2 (n=12)  POD 4 (n=10)  POD 6 (n=8) 
Pain type and descriptors  M     (SD)  M     (SD)  M     (SD) 
Continuous pain   3.39 (2.51)  3.17 (1.85)  2.40 (1.91) 
    Throbbing pain   4.92 (4.56)  5.20 (3.94)  3.63 (3.93) 
    Cramping pain   0.42 (1.44)  1.00 (3.16)  1.00 (2.83) 
    Gnawing pain   1.92 (3.50)  3.10 (4.18)  1.75 (3.28) 
    Aching pain    4.42 (4.38)  2.40 (3.27)  1.88 (2.64) 
    Heavy pain    3.42 (4.30)  2.20 (2.94)  1.25 (2.38) 
    Tender    5.25 (3.82)  5.10 (3.84)  4.88 (3.27) 
 
Intermittent pain   4.03 (2.36)  3.90 (3.27)  1.58 (1.68) 
    Shooting pain   3.75 (4.20)  4.90 (4.56)  1.38 (2.67) 
    Stabbing pain   4.50 (4.74)  3.50 (4.04)  2.75 (3.15) 
    Sharp pain    7.17 (2.86)  5.90 (3.54)  2.88 (3.31) 
    Splitting pain   3.08 (4.17)  3.10 (4.28)  0.50 (1.41) 
    Electric-shock pain   0.83 (2.89)  3.10 (4.28)  1.50 (2.83) 
    Piercing    4.83 (4.51)  2.90 (4.01)  0.50 (1.41) 
 
Neuropathic pain   3.46 (2.80)  2.50 (2.36)  1.77 (1.29) 
    Hot-burning pain   4.08 (4.36)  2.20 (3.74)  2.13 (3.48) 
    Cold-freezing pain   1.67 (3.28)  0.70 (2.21)  0.0 
    Pain caused by light touch  5.25 (4.18)  4.90 (4.33)  4.25 (3.45) 
    Itching    4.17 (4.13)  3.60 (3.53)  2.25 (2.87) 
    Tingling / pins and needles  2.75 (4.14)  1.90 (4.01)  0.63 (1.77) 
    Numbness    2.83 (4.24)  1.70 (2.95)  1.38 (2.56) 
 
Affective description   3.94 (2.72)  1.90 (2.21)  1.06 (1.71) 
    Tiring-exhausting   6.58 (3.58)  3.50 (3.95)  2.00 (2.78) 
    Sickening    3.67 (4.60)  0.0   0.0 
    Fearful    2.08 (3.96)  1.80 (3.82)  0.87 (2.48) 
    Punishing-cruel   3.42 (4.48)  2.30 (4.00)  1.38 (2.56) 
 
Total score    3.68 (2.27)  2.95 (1.95)  1.76 (1.21) 	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 Table 4 shows the descriptive statistics for present pain, HADS anxiety and depression, 
medication dose, pain description and pain frequency at the three measurement periods.  Present 
pain, anxiety, depression and medication dose show decreases from POD 2 to POD 6.  Similarly, 
the proportion of patients reporting pain descriptions of distressing, horrible, or excruciating 
decreased over the measurement days. 
 
Table 4 
Descriptive Statistics of Present Pain, HADS Anxiety and Depression, Medication Dose, Pain 
Description and Frequency of Pain at POD 2, 4 and 6 
 
     POD 2 (n=12)  POD 4 (n=10)  POD 6 (n=8) 
Measure     M    (SD)  M    (SD)   M    (SD) 
Present pain    5.15 (3.23)  4.64 (2.86)  3.83 (2.87) 
 
HADS 
    Anxiety    6.92 (4.19)  6.40 (3.89)  5.43 (5.80) 
    Depression      7.08 (3.37)  6.60 (4.99)  5.43 (4.96) 
 
Medication dose (mg)   54.31 (37.31)  27.88 (19.75)  23.50 (24.07) 
 
Pain description n (%) 
    No pain    2 (16.7)  1 (  8.3)  2 (16.7) 
    Mild    2 (16.7)  5 (41.7)  2 (16.7) 
    Discomforting   2 (16.7)  1 (  8.3)  3 (25.0) 
    Distressing    3 (25.0)  2 (16.7)  1 (  8.3) 
    Horrible    1 (  8.3)  1 (  8.3) 
    Excruciating   2 (16.7) 
 
Pain frequency n (%) 
    Brief    2 (16.7)  4 (40.0)  2 (25.0) 
    Intermittent    2 (16.7)  3 (30.0)  3 (37.5) 
    Continuous    8 (66.7)  3 (30.0)  3 (37.5) 
 
 
 
	  	   72	  
2b. What are the relationships among pain quality, total pain, type of pain, pain management, 
anxiety, and depression in the immediate post-operative period (POD 2, POD 4, POD 6)?  
 Tables 5 (POD 2), 6 (POD 4) and 7 (POD 6) display the intercorrelations among 
medication dosage, HADS anxiety and depression, present pain, and the SF-MPQ-2 pain 
measures.  Using Cohen’s suggestion that correlations of .50 or greater represent a large effect 
size, there were no large correlations between medication dosage and any of the other measures 
at POD 2.  At POD 4 dosage was related to neuropathic pain intensity (r = .50), and by POD 6 
dosage was strongly related to present pain (r =.58), total SF-MPQ-2 score (r = .76), continuous 
pain intensity (r = .68), intermittent pain ( r = .53) and neuropathic pain intensity (r = .66).   
 At POD 2, HADS anxiety showed a statistically significant correlation with the affective 
descriptors of the SF-MPQ-2 (r = .70).  Depression also showed an inverse correlation with pain 
during this time (r = -.56) but was not statistically significant. There were no other large 
correlations between HADS and other measures at POD 4 (Table 6).  At POD 6 anxiety was 
correlated with present pain (r  = .51), intermittent pain (r = .65) and affective descriptors (r = 
.81), while depression had no strong correlations with the pain measures.  
 On POD 6 (Table 7), present pain showed significant correlations to SF-MPQ-2 (r = .84), 
continuous pain (r =.92), intermittent pain (r = .78) and affective descriptors ( r = .80).  As 
mentioned above, medication dosing had strong correlations with SF-MPQ-2, continuous, 
intermittent and neuropathic pain during this same measurement period. 
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Table 5 
 
Intercorrelations for Medication Dosage, HADS Anxiety and Depression, Present Pain, and SF-
MPQ-2 Pain Dimensions at POD 2 
 
 
Measure   1 2 3 4 5 6 7 8 9 
 
1. Medication dosage  - 
2. Anxiety   .34 - 
3. Depression             -.23 .55 - 
4. Present pain   .43      -.07     -.56 - 
5. SF-MPQ-2 total  .45 .51 .36 .22 - 
6. Continuous pain  .35 .32 .31      -.07 .82** - 
7. Intermittent pain  .44 .28 .31 .01 .78** .60* - 
8. Neuropathic pain  .17 .42 .46 .17 .87** .54 .71** - 
9. Affective description .19 .70* .34      -.09 .50 .36 .42 .34 - 
Note.  *p < .05.  **p < .01. 
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Table 6 
 
Intercorrelations for Medication Dosage, HADS Anxiety and Depression, Present Pain, and SF-
MPQ-2 Pain Dimensions at POD 4 
 
 
Measure   1 2 3 4 5 6 7 8 9 
 
1. Medication dosage  - 
2. Anxiety   .09 - 
3. Depression              .05 .87** - 
4. Present pain   .44       .23       .12 - 
5. SF-MPQ-2 total  .37 .45 .31 .31 - 
6. Continuous pain  .27 .39 .22       .41 .87** - 
7. Intermittent pain  .25 .19 .20 .34 .86** .66* - 
8. Neuropathic pain  .50 .43 .28      -.02 .69* .39 .47 - 
9. Affective description .46 .49 .31       .30 .65* .50 .34 .58 - 
Note.  *p < .05.  **p < .01. 
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Table 7 
 
Intercorrelations for Medication Dosage, HADS Anxiety and Depression, Present Pain, and SF-
MPQ-2 Pain Dimensions at POD 6 
 
 
Measure   1 2 3 4 5 6 7 8 9 
 
1. Medication dosage  - 
2. Anxiety   .02 - 
3. Depression            - .36 .71 - 
4. Present pain   .58       .51      -.02 - 
5. SF-MPQ-2 total  .76* .40      -.02 .84** - 
6. Continuous pain  .68 .13      -.41       .92** .83* - 
7. Intermittent pain  .53 .65 .19 .78* .87** .72* - 
8. Neuropathic pain  .66      -.04     -.08      -.05 .39 .05 .06 - 
9. Affective description .41 .81* .29       .80* .87** .66 .89** .11 - 
Note.  *p < .05.  **p < .01. 
 
Research Question 3 
3a. What is the acceptability and feasibility of a desensitization intervention (recruitment, 
 retention, patient acceptance, ease of use) for lower limb amputees in the post-operative period? 
Issues related to recruitment and retention was discussed previously.  Participants that 
enrolled in the study were administered a feasibility questionnaire on POD 6 or during the last 
visit.  Two patients were discharged before POD 6 without administering the questionnaire.  One 
patient withdrew from the study prior to administering the questionnaire.  Nine patients 
completed the feasibility questionnaire.  All of patients that completed the feasibility 
questionnaire agreed or strongly agreed that the technique was easy to use.  When asked if 
desensitization helped the pain, 87.5% agreed or strongly agreed that it was helpful with 12.5% 
undecided if it helped or not.  All those responding felt that they would continue to use the 
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technique, even after the study was completed.  When asked if they would recommend this 
technique to others that had the same type of surgery, 77.8% strongly agreed and 22.2% agreed.   
The majority of patients felt that they could do it by themselves without any help (89.9%).  Open 
comments about the use of desensitization were also elicited during the study; Table 6 has 
comments provided by the participants.  Overall, the comments received were positive. Table	  8	  
Feasibility	  Questionnaire	  Comments	  (n	  =5)	  Participants	  comments	  
Rubbed	  a	  lot	  longer.	  	  I	  felt	  I	  had	  to,	  to	  help	  the	  pain.	  (P	  1)	  A	  couple	  of	  days	  ago	  I	  would	  not	  have	  believed	  it	  to	  work,	  but	  it	  did.	  	  Stay	  an	  inch	  and	  a	  half	  back,	  if	  not	  it	  will	  hurt.	  (P	  2)	  Eased	  the	  pain	  very	  much.	  (P	  7)	  I	  understand	  the	  importance.	  	  When	  I	  used	  it,	  it	  helped	  to	  knock	  the	  pain	  down	  during	  the	  first	  few	  days.	  	  These	  last	  two	  days	  when	  I	  have	  had	  a	  pain,	  I	  used	  it	  and	  I	  did	  not	  have	  to	  get	  any	  pain	  medicine.	  (P	  8)	  It	  helps.	  I	  didn’t	  think	  it	  would.	  	  I	  think	  everyone	  should	  know	  how	  to	  use	  this	  therapy.	  (P	  9)	  
Note. P = participant  
 
The intervention questionnaire was administered during POD 4 and POD 6 to confirm 
that the participant was complying with the intervention according to protocol.  Questions asked 
were: if they removed the knee immobilizer, massaged over the dressing, used a circular pattern 
to massage, massaged across the limb at least three times, massaged any painful areas, tapped 
across the limb and tapped any painful areas.  See Table 8.  The participants had no difficulty 
with the intervention during either time period.  The majority of participants did not identify any 
one area that was more painful. 
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Table 9 
 
Compliance with the Intervention Protocol 
 
 
              POD 4 (n=10)            POD 6 (n=7) 
Protocol     n %   n % 
Removed immobilizer       8   80   5   71 
Massaged over dressing   10 100   7 100 
Used circular pattern    10 100   7 100 
Massaged across 3 times   10 100   7 100 
Massaged painful area       4   40   3   43 
Tapped across 3 times        9   90   7 100 
Tapped painful area      3   30   3   43 
 
 3b.  How does the desensitization intervention affect self-reported short-term pain in lower limb 
amputees during the immediate post-operative period? 
 Each time the patient performed an intervention they recorded the amount of time they 
applied the intervention in minutes, their pain level just before the intervention and their pain 
level immediately after the intervention.  Table 10 shows the average pre and post intervention 
pain levels for the daily and total interventions.  For the 50 total intervention events, and the 
events at each postoperative day there was a statistically significant decrease in pain from pre-
intervention to post intervention and all the statistical comparisons had a large effect size.  The 
average time spent on the 50 interventions was 4.2 minutes per intervention, with the daily times 
ranging from 3.5 to 5.8 minutes per intervention. 
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Table 10 
Effect of Desensitization Intervention on Pain at POD 2, 3, 4 and 5 
   Pre   Post   
   intervention  intervention  Difference 
POD  n M (SD)  M (SD)  M (SD)  Eta2  
2      8 8.38 (1.60)  5.75 (1.58)  2.63 (1.41)  .80 
3  11 9.09 (1.22)  5.18 (2.14)  3.91 (2.34)  .75 
4  15 7.87 (1.61)  5.17 (1.55)  2.70 (1.44)  .79 
5  16 6.69 (1.25)  4.25 (1.77)  2.44 (1.03)  .86 
Total  50 7.84 (1.65)  4.97 (1.80)  2.87 (1.63)  .76 
Note.  n = the number of events preformed by the sample during that postoperative day. 
All paired comparisons p < .001; All effect sizes indicate a large effect 
 
Summary 
 Although, the SF-MPQ-2 had never been used in the amputation population, it did show 
adequate total score internal consistency reliability when used during the acute period.  The 
HADS anxiety scores did not achieve adequate internal consistency reliability until POD 6, and 
HADS depression reached adequate reliability by POD 4.  This instrument has previously been 
used with amputees but not in an acute care setting.  It is possible the wording on several of the 
HADS questions contributed to the lack of response consistency with persons that have just lost 
their leg.   
 The study sample was primarily female, African American, with either a high school 
degree or less, and an average age of 60 years.  The most common co-morbidities included 
hypertension, diabetes and PVD. The majority of the group controlled preoperative pain by use 
of the oral opioid Oxycodone 5 -325.  General anesthesia was primarily used for the surgical 
procedure.  The majority of the group had the right leg amputated with a primary cause of PVD 
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related to diabetes. Refusal rate of the sample was 48% with the primary reason for refusal being 
fatigue.  Those refusing were primarily African American men.  
 The total pain intensity mean scores decreased over the three measurement days.  
Intermittent pain and affective descriptors with the highest intensity at POD 2 included sharp 
pain, tiring-exhausting, tender, pain caused by light touch, and piercing.  All of the neuropathic 
pain descriptors and affective descriptors decreased from POD 2 to POD 6.  Three continuous 
pain descriptors (throbbing, cramping and gnawing) and one intermittent pain descriptor 
(shooting pain) increased from POD 2 to POD 4 before decreasing on POD 6.  All of the other 
continuous and intermittent pain descriptors decreased over the three measurement days.  By 
POD 6, continuous pain followed by neuropathic pain had higher mean scores.  Descriptors 
during this period included, “tender”, “throbbing” and “pain caused by light touch”. Pain on a 
numerical rating scale, anxiety, depression and medication dosages also showed decreases over 
the measurement time periods.  Pain was noted to be less excruciating or horrible for the 
participant as the study progressed.  
Intercorrelations among pain measures, anxiety, depression and medication dosage were 
analyzed for the three time intervals. Large correlation effects (r ≥.50) were noted starting on 
POD 4 with neuropathic pain strongly related to medication dosage.  On POD 6, medication 
dosage was strongly correlated to present pain, SF-MPQ-2 total score, continuous pain, and 
neuropathic pain.  At POD 6, anxiety was strongly correlated with present pain, intermittent pain 
and affective descriptors, while depression had no strong correlations with any of the pain 
measures.   
 Acceptability and feasibility were measured by compliance with the protocol, a 
feasibility questionnaire administered on the last day and patient records of times intervention 
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was used with pain scores.  Compliance with the protocol was high on POD 4 and 6. Participants 
felt that the intervention was easy to use and helped the pain. They said that they would continue 
to use it and they would recommend to others.  Comments were positive about the intervention.  
The effect of desensitization on pain was recorded each time the participant self-administer the 
protocol.  The participants administer a total of 50 interventions with an average administration 
time of 4.2 minutes per each intervention.  Scores showed a decrease in pain scale from pre-
intervention to post intervention with statistically significant paired comparisons and a large 
effect size for POD 2, 3, 4 and 5.   
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
Chapter 5:  DISCUSSION 
 Pain from amputation is not well understood due to the multidimensional nature of pain 
and the unexplained pathophysiological pathway of phantom pain.   Unidimensional treatment 
may not help alleviate post surgical pain in the amputee.  The primary goal of this study was to 
evaluate the feasibility and efficacy of using desensitization with a regular pain regimen of 
medications in those sustaining a lower extremity amputation during acute hospitalization.   A 
secondary purpose of the study was to explore relationships of variables that contribute to 
neuropathic and non-neuropathic pain, as well as, affective descriptors and to explore patterns 
and types of pain in this population.  This chapter presents major findings of the study, 
limitations of the study, recommendations for future research and implications for nursing 
practice.  
Characteristics of the Study Sample 
 The study sample primarily consisted of women (58.3%), African Americans (66.7%) 
and people educated below the high school level (41.7%) with a mean age of 60.  This sample 
was different than samples from previous studies that reported on post-operative pain in 
amputees. The current sample included a higher percentage of women when compared to prior 
studies. Previous studies were predominantly populated by a large percentage of men (60 -91%) 
(Bosmans et al., 2010; Castillo et al., 2006; Ehde et al., 2000; Ephraim et al., 2005; Gallagher et 
al., 2001; Hanley et al., 2006b; Hanley et al., 2007; Hirsch et al., 2010; Richardson et al., 2007; 
Ziegler-Graham et al., 2008).   
Another difference in the current sample compared to previous studies was mean age. 
The sample for this study tended to be older than most other studies. (Bosmans et al., 2010; 
Castillo et al., 2006; Ehde et al., 2000; Ephraim et al., 2005; Gallagher et al., 2001; Hanley et al., 
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2006a; Hanley et al., 2007; Hirsch et al., 2010).  In previous studies traumatic amputations were 
part of the sample, which would lower the age of the sample.  Since vascular disease does affect 
primarily adults that are older, the current sample was older.  When looking at ethnicity of 
previous samples there is a large divergence between this study and other studies.  Prior studies 
included mainly Caucasian individuals (81%-92%) compared to the high percentage of African 
Americans (66.7%) in this study (Ehde et al., 2000; Ephraim et al., 2005; Hanley et al., 2006b; 
Hanley et al., 2007; Hirsch et al., 2010; Ziegler-Graham et al., 2008). No studies were found in 
the literature specific to ethnicity and difference in amputation pain type and description.  This is 
an area that needs to be researched further, in order to provide culturally sensitive and 
appropriate treatment measures. 
 A final demographic characteristic that was unlike other studies was education level.  In 
this study, almost half of the participants had an education level below high school, while other 
studies have reported participants having primarily a high school or greater than high school 
education (Castillo et al., 2006; Ephraim et al., 2005; Hanley et al., 2006b; Hirsch et al., 2010).  
Demographic characteristics may be different due to the geographic location of the studies.  Very 
few studies have been completed with amputees in the southeastern part of the United States.  A 
majority of the studies were either international or conducted in the northwestern or northeastern 
United States (Bosmans, et al., 2010; Castillo et al., 2006; Ehde et al., 2000; Gallagher et al., 
2001; Hanley et al., 2006b; Hanley et al., 2007; Hirsch et al., 2010; Richardson et al., 2007).  
Only one national study included subjects from the south (Ephraim et al., 2005).  Using this 
population provides insight to amputation pain and treatment in this geographic area.  
Clinical characteristics of this study included level of amputation, side amputated, cause 
of amputation, measures for pain control prior to surgery and anesthesia type.  In this study the 
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right leg (66%) was amputated more often and occurred primarily as a BKA (50%). Level of 
amputation of this study is consistent with most studies (Bosmans et al., 2010; Ehde et al., 2000; 
Ephraim et al., 2005; Gallagher et al., 2001; Hanley et al., 2006b; Ziegler-Graham et al., 2008).   
Previous studies have not reported on which side was amputated.  The primary cause of 
amputation in this study was peripheral vascular disease caused by diabetes.  Only one other 
study had similar rates of peripheral vascular disease, but did not specify if it was related to other 
comorbid disease states (Bosmans et al., 2010).  Comorbidities of the sample were similar to 
other studies.  In this study all participants had a medical history of hypertension.  Peripheral 
vascular disease and diabetes were the next two most cited comorbid conditions.  
Pre-operative pain control of the sample was achieved by pharmacologic management 
with oral medication.  The two primary drugs given for pain control were Oxycodone 5-325 
milligrams and Gabapentin. This study supported what other studies have found for pain control 
measures both before and after surgery (Huse et al., 2001, Wu et al., 2002, Wilder-Smith et al., 
2005).  A question asked during the study was to list all types of pain control methods, other than 
pharmacologic, used to alleviate the pain prior to surgery.  None of the participants used any 
other type of complimentary or alternative pain relief methods. This finding is significant in that 
it suggests that patients are not familiar with complementary therapies that may be useful in 
controlling pain.  Studies have shown that health care providers do not supply the amputee with a 
means of adequately controlling their pain either by pharmacologic or non-pharmacologic 
measures and that there is a general lack of knowledge on the types of pain experienced 
(Dudgeon et al., 2002; Hanley et al., 2006b; Mortimer et al., 2002; Smith et al., 1999; Warms et 
al., 2005).  Research on how providers inform the amputee about both pre- and post-operative 
management of pain needs further exploration.   
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Patterns and Relationships of Pain, Anxiety and Depression  
The current study showed that overall mean pain scores during the intervention period 
decreased. Using the SF-MPQ-2 provides the researcher with information on neuropathic, non-
neuropathic pain and affective descriptors.  A new finding of the study was that the SF-MPQ-2 
measure of pain types, pain description and pain intensity found variability in those measures 
among participants and between postoperative days in this population.  Due to the 
multidimensional nature of amputation pain, this instrument provides insight to these types of 
pain and mediators of pain.  Descriptors noted in the study population during all measurement 
time periods included words related to continuous, intermittent and neuropathic pain.  Most 
studies have measured amputation pain after it has been a number of years since surgery and 
found that the primary type of pain experienced by amputees was neuropathic (Flor, 2002; 
Nikolajsen & Jensen, 2001; Wiffen et al., 2006).  This study found that neuropathic and non-
neuropathic pain occurs immediately after surgery. At POD 2, pain descriptors with the largest 
intensity scores included “sharp pain” (intermittent), “tiring-exhausting” (affective), “tender” 
(continuous) and “pain caused by light touch” (neuropathic). At POD 4 the same POD 2 
descriptors were still reported with large intensity scores along with two new descriptors, 
“throbbing” (continuous) and “shooting pain” (intermittent).   On POD 6 most of the pain 
measures were much lower compared to POD 2 and POD 4.  Only the pain descriptors of 
“tender” (continuous) and “pain caused by light touch” (neuropathic) remained high.  The 
descriptor indicating neuropathic pain (phantom limb pain) in this population was “pain caused 
by light touch”, which occurred during all measurement times. The descriptor for neuropathic 
pain in this study is different from other studies (Dudgeon et al., 2005; Ehde et al., 2000; 
Mortimer et al., 2002).  Descriptors related to non-neuropathic pain (residual limb pain) in this 
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study consisted of “sharp pain”, “shooting”, “tender” and “throbbing”.  The descriptors in this 
study were similar to results found by Ehde et al. (2000) for non-neuropathic pain.  Differences 
in pain description may be related to instrument use among the various studies.  Dudgeon et al. 
and Mortimer et al. used instruments that were individualized for their studies. Ehde et al. used 
an earlier version of the MPQ.   All prior studies were done on samples that were in a chronic 
pain state. The sample of this study all used the intervention so variability and reduction in SF-
MPQ-2 cannot be attributed to the intervention.  More studies need to be done on pain 
description and patterns within various populations using a comparative sample. 
In this study, there was also a noted decrease in pain frequency over time. Pain became 
less continuous and more intermittent and brief.  At the same time, the participant’s classification 
of the quality of the pain changed from excruciating/horrible to mild/discomforting during the 
post-operative period.   As pain decreased there was also a decrease in medication dosages.  
Although, the typical surgical patient should use less medication as time continues after surgery, 
the multidimensional nature of the amputee’s pain is different.  Some researchers suggest that 
neuropathic pain does not usually decrease with time after amputation surgery, but becomes 
chronic with increasing intensity (Castillo et al., 2006; Ephraim et al., 2005, Hanley et al., 2006b; 
Kern et al., 2012).  This study was not designed to examine the nature of chronic pain.  
There were no significant relationships among medication dosing, continuous pain, 
intermittent pain or neuropathic pain during POD 2.  By POD 4, medication dosage was strongly 
related to neuropathic pain with increased neuropathic pain intensity associated with higher pain 
medication dosage. On POD 6 medication dosage was strongly related to continuous pain, 
intermittent pain, neuropathic pain and present pain scores.  Present pain during this time showed 
a statistically strong correlation with affective descriptors, SF-MPQ-2, continuous and 
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intermittent pain. The strong correlations during POD 6 between pain types, affective 
descriptors, medication dosing and present pain could indicate improvement in pain management 
with the participant’s current regimen of pain control measures. All of these correlations 
represent new findings.  
Depression had an inverse strong correlation with present pain during POD 2.  Since the 
HADS did not show internal consistency during this time period, the correlation cannot be 
substantiated. Depression showed no other strong correlations during the study.  This could be 
due to the use of the HADS instrument to measure this variable. Other studies have found that 
depression does exist in persons with limb loss but not all depression was found related to the 
pain experience (Jensen et al., 2002; Price, 2005; Whyte & Niven, 2001).  Anxiety did show 
strong relationships with affective descriptors, intermittent pain and present pain.  Anxiety is an 
affective disorder, so this correlation is expected.  The correlation between anxiety, present pain 
and intermittent pain, indicates that when pain increases so does the patient’s anxiety level.  It is 
unknown why this occurs but could be due to anxiousness of the participant in receiving 
adequate pain control in a timely manner. Only one previous study gave an explanation of the 
correlation between pain and anxiety in the amputee.  Sherman et al. (1979) describes the pain-
anxiety-tension cycle. In this cycle, when muscle tension occurs in the residual limb, anxiety and 
pain level increase.  Relaxation used by Sherman et al. showed a decrease in tension with 
subsequent decrease in anxiety and pain.  No further studies were found discussing the pain-
anxiety-tension cycle in the amputee population.  Even though this is an older study, further 
research should explore this cycle, as well as, correlation of pain and anxiety after amputation.  
Overall, mean anxiety and depression scores did decrease from POD 2 to POD 6. The findings 
related to anxiety and depression must be interpreted with caution due to the lack of internal 
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consistency with a low Cronbach alpha for this instrument up to POD 4.  In further studies 
completed in the acute setting with amputation patients, other anxiety and depression scales may 
need to be considered. 
Feasibility and Efficacy of Desensitization 
There are currently no studies that report the use of desensitization with the amputation 
population.  Any complementary therapy that will assist in pain control needs to be efficacious 
and feasible for the patient to use.  This study is the only one that has measured efficacy and 
feasibility with the technique of self-administered desensitization. This study points to promising 
results for using desensitization, although the results are not definitive.  
All participants of the study used the intervention.  Participants reported that the 
technique was easy to use, they would recommend it to others and would continue to use it.  The 
participants were able to perform the technique by themselves with little to no help.  Most 
importantly, the majority of participants reported that desensitization did help reduce their pain.  
Comments provided by participants supported the use of desensitization, even though some 
participants were initially skeptical that the technique would have any benefit.  All participants 
reported using the protocol correctly.  It is important to note that the technique could be 
performed by a sample that had an educational level that was less than high school, making this 
an easy to follow and simple way to add to their therapeutic pain management plan.  
 Reduction in pain was statistically significant from pre to post intervention with each 
event performed by the participant.  This, along with the positive feasibility results and positive 
comments supports the use of this desensitization protocol.   The difference in pain levels is both 
statistically and clinically significant.  The actual reduction in pain varied from two to five points 
on a numerical rating scale suggesting that patients did feel substantial relief after administering 
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the intervention. Clinically, nursing can provide a way for the amputee to have control over their 
pain without any added cost.  
Theoretical Frameworks 
In order to understand the multidimensional aspect of amputation pain, two frameworks 
guided this study.  Adaptation by anyone having an amputation has to occur on multiple levels.  
Roy’s Adaptation Model describes the focal stimulus as the start of adaptation. Roy suggests that 
adaptation to a focal stimulus like pain requires interventions by the individual and nursing 
within the context of the situation. In this study, the context is the immediate post-operative 
period where the individual is experiencing both non-neuropathic and neuropathic pain.  The 
usual response in dealing with any type of pain is by using opioids.  This study suggests that this 
type of intervention is somewhat effective.  However, the study also suggests that using the 
desensitization protocol within this context augments adaptation at least temporarily while the 
patient is recovering.  
Melzack’s Neuromatrix Theory (1999) was also used to look specifically at neuropathic 
or phantom limb pain in this study.  Melzack’s theory describes how pain is perceived when 
there is no stimulus, such as with a phantom limb. In this study, an attempt to restructure the 
neurosignature was done through desensitization.  Using stimuli at the site to restructure the 
innate pathway through massage and tapping guided by dermatome mapping was reported by 
participants as helping the overall pain experienced after surgery. 
In order to conceptualize a model for amputation pain there needs to be a melding of 
theories to explain the multidimensional nature of the various types of pain experienced.  
Overall, Roy’s Adaptation model and Melzack’s Neuromatrix theory were supported and useful 
in guiding this study.   
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Strengths and Limitations 
A major strength of this study is the diverse population represented.  This study had a 
high representation of African Americans and females.  In most amputation studies these two 
groups are underrepresented.  There are no studies in the literature that examine race with 
neuropathic and non-neuropathic pain after amputation. 
Another strength of the study was exploration of the SF-MPQ-2 and HADS with an 
amputee population during acute hospitalization.  This study confirmed that the SF-MPQ-2 was a 
reliable instrument to use immediately after surgery in this population.  On the other hand, the 
HADS was not reliable immediately after this type of surgery, even though the instrument is 
conceptualized for use in the hospitalized patient.  
Although this was a small pilot study, it is the first time desensitization has been studied 
as a feasible and efficacious technique in the amputation population immediately after surgery.  
The positive result of feasibility along with the effects of decreased pain levels after intervention 
supports the need to find out more about the technique and its effect on amputation pain as a 
complementary measure.   
 The major limitation of this study was sample size.  An initial projection of thirty 
participants was planned.  Due to a large number of refusals and excluded patients, sampling was 
limited to twelve patients. Since this study was done in the immediate period following 
amputation surgery, a majority of potential participants were fatigued due to surgery and 
postoperative therapy.  Sample size was also limited due to an overall decrease in the number of 
amputations performed by the surgical group and limitations within the medical staff.  One way 
to address this is by studying pain management therapies in this population with a multisite study 
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or consenting participants before surgery. Using an interdisciplinary research team who are 
familiar with this population could also increase recruitment.  
Another limitation of the study was sample method.  A convenience sample was used for 
this study without a comparison group.  Since it was an exploratory study, this type of sampling 
was appropriate.  However, a study using random assignment would provide a more rigorous 
evaluation of the effect desensitization might have on pain.  Patients who sustained a traumatic 
amputation were excluded from this study, but could add to the overall sample in future studies. 
Future research studies need to examine traumatic amputation patients using this type of 
desensitization protocol.  
Due to the study sample consisting of primarily older patients with vascular problems and 
small sample size, generalizability of this study is limited.  Patients who sustain traumatic 
amputations are younger and may react differently to pain. Future studies need to consider 
including traumatic amputation patients in examining complementary measures for pain control.  
 This study measured only the short-term effects of the intervention on post acute 
amputation pain.  A limitation of the study and what is not known is the cumulative effect on 
pain types in this population. Research design prevented examining desensitization 
longitudinally, but is an important aspect for future studies.   
Recommendations for Research 
Future research needs to be conducted with a larger representative sample of amputation 
patients. Ideally, desensitization needs to be evaluated using a randomized control trial design 
that includes patients from different socioeconomic and ethnic backgrounds who are receiving an 
amputation for various conditions. Longitudinal studies also need to be conducted in order to 
explore how desensitization over time with chronic pain. Repeating this study during the 
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rehabilitation phase of recovery or in the home setting would help determine if there is a 
cumulative effect and if pain restructuring does occur. 
This is the first study that examined the use of a set protocol of desensitization with the 
amputation population. The findings of this study need to be validated in a larger cohort to better 
understand pain control of the amputee in the post-operative period. Further studies need to 
continue exploring complementary therapies for pain management in the amputee.  Most 
research has examined pain interventions using only one therapy at a time.  There are mixed 
reviews of these studies (Clarke, Lindsay, Pyati & Buchheit, 2013).  Since amputation pain is 
multidimensional and complex, studies should measure multimodal therapies simultaneously. 
Lastly, randomized control studies need to take place during acute hospitalization and acute 
rehabilitative phases.  
Implications for Nursing 
Pain among amputation patients consists of various types of pain; continuous, 
intermittent and neuropathic.  Along with the pain, affective disorders are also present.  Nursing 
needs to understand how to distinguish among the various types of pain in the post-surgical 
amputation patient.  The nurse should be knowledgeable about appropriate treatment measures 
that alleviate these types of pain.   In practice, the clinician needs to recognize high levels of 
anxiety and depression as modulators of pain and be able to implement measures to also resolve 
affective disorders at the same time. 
This study provides support in using the technique of desensitization in the acute 
hospitalization phase for amputation patients. Participants in this study found it easy to use, as 
well as, helpful in alleviating their pain.  Imparting knowledge to patients that aids in outcome 
and recovery is crucial.  Adding this type of therapy to routine care provided by nursing and 
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allied health may improve patient outcomes without added cost to the patient and organization. 
The intervention also gives some control to the patient in managing their pain.  
  One of the largest implications of the study is the need for more research on pain 
interventions provided by nurses for amputation pain during acute post-surgical care.  The focal 
point of care during this period should center on pain relief.  Without adequate pain control, the 
patient is unable to continue with activities of daily living and rehabilitation.  At present, only 
one means of pain relief, pharmacological therapy, is used for multidimensional pain. 
In summary, this pilot study provides beginning information on using one type of 
complementary therapy with amputation patients during acute hospitalization.  Although, the 
sample was small in this repeated measure study, it did give insight to the need for more 
amputation research with a diverse population.  Desensitization was reported by most 
participants as being beneficial.  Nursing is responsible for managing pain in the patient after 
surgery in the acute setting.  It is important to build evidence through nursing research on the 
best strategies for controlling pain caused by limb loss.    	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APPENDIX A:  INSTITUTIONAL REVIEW BOARD APPROVAL LETTER 
 
	  	  
APPENDIX B:  DEMOGRAPHIC AND CLINICAL QUESTIONNAIRE 
Demographic	  and	  Clinical	  Questionnaire	  for	  Study	  on	  Complementary	  Therapy	  for	  
Amputation	  Pain	  
	  1.	  	  	  Gender	  	  	   Male	   	   	  	  	   Female	   	  	  2.	  	  	  Age	  	  	  	  	  	  	  ________________	  	  	   	  3.	  	  	  Highest	  level	  of	  education	  	  	   Less	  than	  high	  school	   	  	   High	  School/GED	   	   	  	   Some	  college	   	   	   	  	   2-­‐year	  college	  degree	   	  	   4-­‐year	  college	  degree	   	  	   Graduate	  degree	   	   	  	  4.	  	  	  Race/Ethnicity	  	  	   African	  American	  (non-­‐Hispanic)	   	   	  	   Hispanic	   	   	   	   	   	  	   Caucasian	  (non-­‐Hispanic)	   	   	   	  	   Asian	   	   	   	   	   	   	  	   Pacific	  Islander	   	   	   	   	  	   Native	  American	   	   	   	   	  	   Other	  (specify)______________________	  5.	  	  Pain	  medication	  used	  at	  time	  of	  admission	  to	  the	  hospital	  (List	  all	  that	  apply	  with	  dose,	  frequency	  and	  route.	  Include	  any	  medication	  used	  for	  any	  chronic	  pain	  syndromes.)	  	  	  	  	  	  	  _________________________________________________________________________________________	  	  	  	  	  	  _________________________________________________________________________________________	  	  	  	  	  	  _________________________________________________________________________________________	  
	  	  
	  	  	  	  	  _________________________________________________________________________________________	  	   	  6.	  	  	  Other	  interventions	  used	  by	  the	  patient	  for	  pain	  relief	  before	  coming	  in	  the	  hospital	  (List	  all	  that	  apply.	  Examples:	  	  Rubbing,	  Cold	  packs,	  Heating	  pads,	  acupuncture)	  	  	  	  _________________________________________________________________________________________________________	  	  	  
Review	  the	  chart	  for	  the	  following	  information.	  	  	  7.	  	  What	  is	  the	  level	  of	  amputation?	  	  	   Above	  the	  knee	   	   	   	  	  	  	   	  	  	  	  	  	  	  	  	   Below	  the	  knee	   	   	  	  	   Knee	  Disarticulation	  	   	  	   	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  8.	  	  What	  side	  was	  amputated	  this	  admission?	  Check	  both	  if	  both	  legs	  were	  	  amputated	  during	  this	  admission.	  	  	  	   Right	   	   	   	  	   Left	   	   	   	  	   	  9.	  	  What	  history	  of	  health	  problems	  does	  the	  patient	  have?	  	  	   Coronary	  Artery	  Disease/Heart	  problems	   	   	   	   	   	  	   Chronic	  Obstructive	  Pulmonary	  Disease	   	   	   	   	   	  	   Peripheral	  Vascular	  Disease/Carotid/Aneurysmal	   	   	   	  	   High	  blood	  pressure	   	   	   	   	   	   	   	   	  	   Diabetes	   	   	   	   	   	   	   	   	   	  	   History	  of	  previous	  amputation	  	   	   	   	   	   	   	  	   Other(s)_______________________________________________	  	  10.	  	  What	  type	  of	  anesthesia	  was	  used	  (include	  medication	  used)?	  	  
	  	  
	   General	   	   	   	   	   	   	   	   	  	   Spinal	   	   	  	   Epidural	   	  	   	  
Anesthetic	  
Medication	  Used	  
Route	   Dose	  in	  mg.	   Used	  during	  
Procdure	  (P)	  or	  	  
Used	  during	  
Induction	  (I)	  	   	   	   	  	   	   	   	  	   	   	   	  	   	   	   	  	   	   	   	  	   	   	   	  	  11.	  	  	  What	  pain	  medication	  was	  the	  patient	  placed	  on	  in	  the	  postoperative	  period?	  (Postoperative	  Day	  0	  =	  POD	  0;	  Postoperative	  Day	  1	  =	  POD	  1).	  	  Please	  list	  medication	  name,	  route	  and	  cumulative	  dosage	  for	  each	  day	  (24	  hour	  period	  beginning	  at	  midnight	  to	  midnight).	  If	  patient	  has	  an	  epidural,	  list	  all	  medications	  that	  the	  solution	  has	  mixed	  in	  the	  bag	  if	  it	  is	  a	  mixture.	  	  	  	   Medication	   Route	   Dose	  in	  mg./6	  hr	  
intervals	  
POD	  0	   	   	   	  00:00-­‐06:00	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  06:01-­‐12:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12:01-­‐18:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18:01-­‐24:00	   	   	   	  
POD	  1	   	   	   	  00:00-­‐06:00	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  06:01-­‐12:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12:01-­‐18:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18:01-­‐24:00	   	   	   	  
	  	  
POD	  2	   	   	   	  00:00-­‐06:00	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  06:01-­‐12:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12:01-­‐18:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18:01-­‐24:00	   	   	   	  
POD	  3	   	   	   	  00:00-­‐06:00	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  06:01-­‐12:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12:01-­‐18:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18:01-­‐24:00	   	   	   	  
POD	  4	   	   	   	  00:00-­‐06:00	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  06:01-­‐12:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12:01-­‐18:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18:01-­‐24:00	   	   	   	  
POD	  5	   	   	   	  00:00-­‐06:00	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  06:01-­‐12:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12:01-­‐18:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18:01-­‐24:00	   	   	   	  
POD	  6	   	   	   	  00:00-­‐06:00	  	  	  	   	   	   	  
	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  06:01-­‐12:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12:01-­‐18:00	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18:01-­‐24:00	   	   	   	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
APPENDIX C:  JOURNAL CARD 
Time	  of	  Day	  	   How	  long	  did	  
you	  rub/tap	  
(minutes)	  
What	  was	  your	  
pain	  before	  
you	  started	  on	  
a	  scale	  of	  1	  (no	  
pain)	  to	  10	  
(worst	  pain)	  
What	  was	  your	  
pain	  after	  you	  
finished	  on	  a	  
scale	  of	  1	  (no	  
pain)	  to	  10	  
(worst	  pain)	  
Who	  did	  the	  
rubbing	  and	  
tapping	  
	   	   	   	   	  	   	   	   	   	  	   	   	   	   	  	   	   	   	   	  	   	   	   	   	  	   	   	   	   	  	  
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
APPENDIX D:  DESENSITIZATION PROTOCOL 
Desensitization	  Protocol	  Guideline	  for	  Practitioner	  	  	  1.	  	  Provide	  a	  quiet	  environment	  for	  the	  patient.	  	  	  	  2.	  	  Explain	  to	  patient	  and	  family	  member	  that	  this	  is	  a	  training	  session.	  	  At	  the	  end	  you	  would	  like	  the	  patient	  and/or	  family	  member	  to	  show	  you	  how	  to	  perform	  the	  desensitization	  technique.	  	  	  3.	  	  Describe	  the	  technique	  of	  desensitization	  	  (It	  is	  a	  technique	  to	  help	  with	  your	  pain.	  	  It	  can	  be	  used	  for	  both	  types	  of	  pain	  you	  are	  experiencing.	  	  Desensitization	  is	  a	  gentle	  tapping	  on	  the	  dressing	  above	  the	  incision	  line	  and	  then	  a	  gentle	  rubbing	  of	  the	  residual	  limb.)	  	  4.	  	  Wash	  hands.	  	  5.	  Apply	  gloves.	  	  6.	  	  Tell	  the	  patient	  when	  you	  are	  going	  to	  begin.	  	  	  7.	  Remove	  the	  knee	  immobilizer	  (if	  one	  is	  present)	  leaving	  the	  compression	  dressing	  	  	  	  	  	  intact.	  	  The	  compression	  dressing	  may	  be	  an	  ace	  wrap	  or	  a	  shrinker.	  	  	  8.	  	  Inspect	  the	  bandage.	  	  If	  a	  large	  amount	  of	  active	  bleeding	  is	  noted	  (bright	  red)	  	  	  then	  defer	  the	  treatment	  and	  report	  this	  to	  the	  nurse	  so	  the	  physician	  can	  be	  notified.	  	  If	  dried	  blood	  present,	  desensitization	  can	  proceed.	  	  9..	  	  Putting	  your	  index	  and	  middle	  finger	  together,	  position	  these	  1	  inch	  above	  the	  end	  of	  the	  residual	  limb.	  	  Use	  a	  centripetal	  direction	  by	  gently	  tapping	  from	  the	  lateral	  edge	  of	  the	  incision	  inward	  to	  the	  proximal	  edge	  in	  a	  rhythmic	  motion.	  	  The	  nail	  beds	  of	  the	  practitioner	  should	  remain	  pink	  and	  without	  blanching	  of	  the	  nail	  bed	  (level	  1	  pressure)	  .	  If	  blanching	  occurs,	  then	  the	  pressure	  is	  too	  great.	  	  	  10.	  	  Repeat	  this	  three	  times	  without	  change	  in	  pressure.	  	  	  	  11.	  	  Inform	  the	  patient	  that	  you	  will	  now	  be	  gently	  massaging	  the	  limb	  in	  the	  same	  pattern	  that	  you	  used	  for	  the	  tapping.	  	  	  12.	  	  Ask	  if	  there	  is	  a	  certain	  part	  of	  the	  patient’s	  phantom	  leg	  or	  foot	  that	  is	  hurting.	  	  13.	  	  Use	  the	  index,	  middle	  and	  ring	  finger	  together	  for	  massaging.	  	  Press	  down	  using	  a	  pressure	  where	  the	  fingertips	  blanch	  but	  the	  nail	  beds	  do	  not	  change	  color	  (level	  2	  pressure).	  	  Starting	  at	  the	  lateral	  side	  of	  the	  limb,	  massage	  in	  a	  circular	  pattern	  using	  a	  centripetal	  pattern.	  	  Do	  not	  lift	  fingers,	  but	  continue	  motion	  back	  across	  the	  limb	  to	  the	  
	  	  
lateral	  aspect	  of	  the	  limb	  or	  centrifugal	  pattern.	  Continue	  this	  massage	  for	  three	  repeated	  patterns.	  	  14.	  	  If	  the	  patient	  has	  an	  area	  on	  the	  phantom	  limb	  that	  is	  painful	  or	  hurts,	  locate	  the	  area	  by	  using	  the	  charts	  provided	  that	  corresponds	  to	  areas	  on	  the	  residual	  limb.	  Use	  the	  same	  massage	  technique	  in	  this	  area	  only.	  	  Massage	  the	  area	  for	  1	  minute.	  	  Reassess	  the	  pain	  in	  the	  phantom	  limb	  using	  the	  numerical	  rating	  scale.	  	  	  Repeat	  for	  another	  minute.	  	  Reassess	  pain	  by	  using	  the	  numerical	  scale.	  	  Repeat	  a	  third	  and	  final	  time.	  	  Reassess	  pain	  after	  completion.	  	  Repeat	  for	  any	  other	  areas	  noted	  by	  patient.	  	  	  	  15.	  	  Allow	  the	  patient	  to	  rest	  for	  five	  minutes.	  	  16.	  Ask	  the	  patient	  and	  or	  family	  member	  to	  repeat	  the	  desensitization	  technique.	  	  Guide	  the	  patient	  or	  family	  member	  as	  needed.	  	  	  17.	  	  Instruct	  the	  patient	  or	  family	  member	  to	  repeat	  this	  technique	  every	  three	  hours	  while	  awake	  or	  when	  the	  patient	  first	  begins	  hurting.	  	  	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
APPENDIX E:  INTERVENTION QUESTIONNAIRE 
 
	  	  
APPENDIX F:  FEASIBILITY QUESTIONNAIRE 
Desensitization Feasibility Questionnaire for Study on Complementary Therapy for 
Amputation Pain 
 
1. The technique was easy to use. 
 
o Strongly Agree 
o Agree 
o Undecided 
o Disagree 
o Strongly Disagree 
 
2.  The rubbing and tapping  helped my pain. 
 
o Strongly Agree 
o Agree 
o Undecided  
o Disagree 
o Strongly Disagree 
 
3.  I will continue to use it.  
 
o Strongly Agree 
o Agree 
o Undecided 
o Disagree 
o Strongly Disagree 
 
4.  I would recommend this therapy to others that have had this type of surgery.  
   
o Strongly Agree 
o Agree 
o Undecided 
o Disagree 
o Strongly Disagree 
 
5.  I needed help using it this therapy. 
 
o Always 
o Very Often 
o Sometimes 
o Rarely 
o Never 
  
Any thing you would like to add: 
 
 
	  	  
APPENDIX G:  PATIENT BOOKLET 
 
Added	  Therapy	  for	  Amputation	  Pain©	  	  (A-­‐TAP)	  	  	  	  
	  	  
©	  Carolyn E. Horne, 2012 
	  	  
	  
Pain	  after	  Surgery	  	  It	  is	  normal	  to	  have	  pain	  after	  amputation	  surgery.	  	  You	  may	  experience	  different	  types	  of	  pain.	  	  One	  type	  of	  pain	  is	  the	  pain	  that	  everyone	  experiences	  after	  surgery.	  	  It	  is	  usually	  located	  at	  or	  near	  the	  incision.	  	  Another	  type	  of	  pain	  you	  may	  experience	  is	  called	  “phantom	  limb	  pain”.	  	  This	  type	  of	  pain	  is	  felt	  in	  the	  leg	  that	  was	  removed.	  	  The	  leg	  is	  not	  there	  but	  you	  still	  feel	  pain	  in	  the	  leg.	  	  	  This	  is	  normal.	  	  Most	  amputees	  experience	  phantom	  limb	  pain.	  	  Your	  health	  care	  team	  should	  or	  already	  has	  ordered	  you	  medicine	  for	  your	  pain.	  	  Your	  nurse	  should	  provide	  you	  with	  pain	  medicine	  when	  you	  need	  it.	  	  Sometimes	  the	  pain	  may	  not	  go	  away	  even	  with	  the	  medicine.	  	  It	  may	  take	  other	  types	  of	  therapy	  to	  help	  you	  get	  relief	  from	  the	  pain.	  	  	  One	  therapy	  to	  help	  with	  pain	  is	  called	  desensitization	   	  [dee-­‐sen-­‐si-­‐tuh-­‐zey-­‐shuhn].	  	  This	  may	  help	  to	  ease	  the	  pain	  when	  done	  routinely	  or	  when	  you	  are	  experiencing	  pain.	  Desensitization	  is	  done	  by	  tapping	  the	  amputated	  leg	  above	  the	  incision	  and	  following	  this	  by	  rubbing	  the	  same	  area.	  	  Doing	  this	  may	  or	  may	  not	  help	  the	  pain	  to	  ease.	  	  Using	  pain	  medicine	  and	  desensitization	  together	  could	  help	  with	  your	  relief	  of	  pain.	  	  
	  	  
	   Pain	  in	  the	  Phantom	  Limb	  	  The	  experience	  of	  pain	  in	  the	  missing	  limb	  is	  very	  real.	  	  The	  pain	  may	  be	  experienced	  in	  the	  entire	  missing	  limb	  or	  it	  may	  be	  in	  just	  one	  area	  of	  the	  limb,	  such	  as	  the	  right	  side	  of	  the	  foot	  or	  a	  toe.	  	  Being	  able	  to	  ease	  the	  pain	  in	  a	  certain	  area	  of	  the	  missing	  leg	  or	  foot	  can	  be	  difficult	  and	  frustrating.	  	  In	  order	  to	  do	  this,	  you	  can	  use	  the	  same	  tapping	  and	  rubbing	  technique	  used	  for	  desensitization.	  	  The	  area	  of	  the	  foot	  or	  leg	  that	  is	  hurting	  corresponds	  to	  the	  same	  side	  or	  location	  on	  the	  leg	  that	  remains.	  	  You	  can	  rub	  or	  tap	  the	  area	  of	  the	  limb	  on	  the	  same	  side	  of	  the	  painful	  area.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  
	  	   Guide	  to	  Performing	  Pain	  Control	  Therapy	  	  1.	  	  Make	  sure	  that	  you	  are	  in	  a	  relaxed	  place.	  	  	  2.	  	  Your	  dressing	  and/or	  shrinker	  should	  remain	  on.	  	  3.	  	  Take	  your	  index	  finger	  and	  middle	  finger	  and	  put	  them	  	  	  	  	  	  	  together	  like	  in	  Figure	  1.	  Place	  your	  fingers	  1	  to	  2	  inches	  above	  your	  surgery	  line	  (Figure	  2.).	  Begin	  tapping	  along	  this	  line	  gently.	  	  It	  is	  like	  tapping	  on	  the	  desk	  with	  two	  fingers.	  	  Tap	  from	  the	  outside	  of	  your	  leg	  toward	  the	  inside	  of	  the	  leg	  (Figure	  3).	  	  You	  should	  do	  this	  with	  a	  quick	  tap.	  Do	  not	  use	  pressure	  or	  force	  to	  tap.	  	  It	  should	  feel	  like	  light	  pressure	  but	  should	  not	  be	  painful.	  	  If	  it	  is	  painful	  then	  you	  may	  stop.	  	  	  	  	  	  	  	  
	  	   	  	   	   	  	  	  
	  	  
	  	  
	  	  4.	  	  Repeat	  the	  tapping	  pattern	  three	  times.	  	  5.	  	  The	  next	  step	  is	  to	  take	  your	  three	  fingers,	  like	  used	  in	  a	  boy	  scout	  salute	  (Figure	  4.).	  	  	  Place	  them	  1	  inch	  above	  the	  incision	  area,	  like	  in	  Figure	  2	  above.	  Begin	  rubbing	  above	  the	  incision	  in	  a	  circular	  pattern	  (Figure	  5),	  starting	  from	  the	  outside	  of	  your	  leg	  and	  working	  to	  the	  inside.	  	  This	  should	  be	  slower	  than	  the	  tapping.	  When	  you	  get	  to	  the	  inside	  of	  the	  leg,	  do	  not	  lift	  your	  fingers	  but	  continue	  to	  rub	  back	  to	  the	  outside	  of	  the	  leg.	  	  Do	  this	  three	  times	  (one	  time	  is	  considered	  going	  across	  and	  back).	  	  	  	  	  
	  	  
	  	  
Figure	  4.	  	  Use	  three	  fingers	   	   	   	  	  	  	  	  	  	  	  	  	  
	  	  	  	  6.	  	  If	  you	  have	  a	  spot	  on	  your	  missing	  or	  phantom	  leg	  that	  is	  	  	  	  	  	  painful	  or	  itching,	  try	  to	  locate	  the	  pain	  or	  itch	  on	  the	  leg	  that	  remains.	  	  Use	  the	  color-­‐coded	  map	  below	  to	  locate	  the	  point	  on	  your	  remaining	  leg	  that	  you	  can	  tap	  and	  rub	  to	  relieve	  the	  spot	  on	  your	  missing	  leg	  that	  is	  giving	  you	  the	  problem.	  	  See	  Figure	  8.	  for	  the	  areas	  that	  relate	  to	  the	  missing	  part	  of	  the	  leg.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  
	  	  	  	  
	  	  	  
	  	  
	  	  	  
	  	  
	  	  
	  	  	  	  	  	  7.	  	  Rub	  and	  tap	  like	  described	  above	  on	  the	  spot	  you	  located.	  	  Use	  the	  same	  pattern	  until	  you	  feel	  that	  the	  spot	  that	  is	  painful	  or	  itching	  is	  getting	  better.	  	  	  	  8.	  	  In	  order	  for	  you	  to	  get	  pain	  relief	  from	  your	  phantom	  limb,	  you	  need	  to	  repeat	  this	  every	  three	  hours	  while	  you	  are	  awake.	  	  Doing	  this	  regularly	  will	  help	  the	  skin	  and	  nerves	  to	  heal.	  	   	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
 
 
 
